hg_45101.1

Basic information about the TSS

---

TSS ID: hg_45101.1 Species: human Chr: chr3		Start: 150546382 End: 150546393 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AB022427 Distance: 35 GeneID: 27230 HGNC/MGI_ID: HGNC:10759 UniProt_ID:

Gene_name: stress associated endoplasmic reticulum protein 1 Gene_symbol: SERP1 Gene_synonyms: FLJ43424 RAMP4 Gene_source: HGNC:10759

TATA-Box annotation

---

Distance to TSS:	108
Nearest PromoterID:	NM_014445
Entrez ID:	27230
Nearest Unigene:	Hs.518326
Nearest Refseq:	NM_014445
Nearest Ensembl:	ENSG00000120742
Gene Name:	stress associated endoplasmic reticulum protein 1
Gene Alias:	RAMP4
Gene Description:	stress associated endoplasmic reticulum protein 1
Gene Type:	protein-coding
CpG%:	0.16
GC%:	0.716418
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SERP1 p2@SERP1 p3@SERP1 p4@SERP1 p5@SERP1 p6@SERP1 p7@SERP1 p8@SERP1 p9@SERP1
Sample		p1@SERP1	p2@SERP1	p3@SERP1	p4@SERP1	p5@SERP1	p6@SERP1	p7@SERP1	p8@SERP1	p9@SERP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	100.13	40.91	24.74	5.45	3.12	2.53	1.75	0.58	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	103.99	36.21	25.29	4.25	5.46	1.82	2.02	0.20	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	99.35	40.12	22.76	4.24	3.47	2.70	1.35	0.39	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	82.75	46.78	27.65	3.74	5.82	2.49	2.49	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	88.86	46.12	27.90	4.05	5.85	2.70	1.35	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	94.58	47.68	32.17	2.91	3.68	3.49	2.52	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	133.13	59.26	30.29	6.10	7.41	4.58	2.83	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	119.66	49.17	28.58	3.39	8.24	3.63	4.36	0.48	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	122.89	53.00	28.42	4.49	7.05	3.42	3.21	0.43	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	74.19	45.79	23.19	13.33	13.91	4.06	3.48	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	92.57	40.42	25.87	12.53	9.70	4.45	4.45	0.40	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	78.46	43.91	23.17	8.13	16.67	5.29	5.29	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	77.53	64.96	8.22	5.32	0.81	0.97	1.13	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	68.41	58.19	7.82	6.01	1.05	0.45	1.20	0.00	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	75.97	55.55	7.90	5.27	0.66	0.44	0.88	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	67.65	54.32	6.54	4.78	1.51	1.01	2.01	0.25	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	72.07	53.07	10.70	4.59	0.44	0.66	1.09	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	67.49	71.71	9.70	2.95	0.00	0.42	0.84	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	77.31	65.04	8.53	1.60	0.53	0.53	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	79.43	75.22	8.42	4.66	1.20	1.50	1.20	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	76.98	62.01	11.76	3.61	1.07	0.80	1.07	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	76.13	63.01	11.91	3.80	2.07	0.86	2.07	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	63.47	55.84	9.18	2.97	0.65	0.65	0.13	0.52	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	67.22	63.58	12.62	3.15	0.73	1.21	0.49	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	84.36	65.53	13.67	2.84	1.81	0.52	1.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	88.31	75.01	15.51	4.43	1.90	1.58	0.95	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	72.53	76.92	10.44	3.85	2.20	0.55	1.10	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	79.92	53.28	11.79	2.59	1.41	1.18	1.41	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	94.17	71.55	13.08	2.91	1.62	0.97	0.97	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	76.01	52.48	11.40	3.08	0.90	0.90	0.36	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	76.62	53.59	12.77	3.35	0.84	1.05	0.84	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	78.74	61.55	10.55	3.91	0.98	0.20	0.98	0.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	75.97	65.42	13.29	2.32	1.27	0.84	1.69	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	80.66	59.38	12.04	6.60	1.15	1.15	2.14	0.33	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	73.49	60.02	14.59	2.62	2.24	1.12	1.31	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	75.50	64.00	13.41	1.92	1.15	1.34	1.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	76.85	59.68	14.51	4.50	1.84	1.84	1.02	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	72.13	60.04	11.08	3.43	1.01	1.41	0.81	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	89.40	69.69	14.59	6.75	1.62	1.35	1.62	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	81.86	57.85	13.44	3.12	2.16	2.16	0.72	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	75.75	55.29	11.29	4.47	1.41	0.94	0.94	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	82.27	69.10	14.49	4.54	1.02	1.61	1.17	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	93.43	61.37	17.29	2.95	2.11	1.05	0.63	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	79.72	66.08	15.73	3.15	2.10	2.27	1.57	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	99.58	67.66	21.48	5.02	2.81	2.01	2.01	0.20	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	97.48	65.37	20.94	2.79	3.02	1.86	1.63	0.70	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	95.96	58.78	18.47	2.40	1.44	4.08	1.68	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	107.30	68.55	19.37	4.47	1.79	2.68	1.79	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	120.88	66.07	26.33	3.11	1.20	2.39	2.39	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	120.51	73.40	23.86	4.04	2.63	3.24	3.24	0.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	100.02	62.10	22.13	4.10	3.48	2.46	2.25	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	126.75	66.05	29.13	3.78	5.56	4.45	1.11	0.89	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	27.98	27.98	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	136.27	63.16	34.07	2.84	3.19	1.06	1.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	141.50	62.30	36.45	1.99	2.32	3.65	2.65	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	106.55	53.69	19.30	12.58	0.00	5.87	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	129.05	60.62	28.47	10.56	3.21	5.51	1.84	0.92	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	152.01	61.90	33.38	2.27	1.94	4.21	2.27	1.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	151.27	46.25	34.37	2.89	3.53	1.93	3.53	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	130.76	63.81	28.92	6.60	3.14	3.77	0.63	0.31	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	111.40	73.33	35.25	2.82	1.41	2.82	2.12	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	139.64	60.57	34.77	1.68	1.68	3.36	1.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	75.63	42.99	8.76	3.18	2.39	4.78	2.39	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	99.55	66.59	21.75	3.40	5.44	3.06	2.38	0.00	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	115.35	56.21	21.77	1.62	1.95	2.92	2.27	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	117.50	57.15	23.43	1.06	1.06	3.19	1.06	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	32.33	32.33	16.16	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	55.28	7.90	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	137.97	68.74	27.79	1.95	0.00	1.46	1.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	172.56	75.37	33.72	1.98	1.98	1.98	0.99	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	151.05	69.90	32.37	1.41	1.41	1.41	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	139.76	68.89	19.21	4.97	1.32	2.65	0.99	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	141.68	78.88	30.32	2.17	1.55	1.55	0.93	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	138.81	72.77	23.24	3.36	1.22	2.14	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	148.25	51.63	22.97	1.74	1.90	3.48	0.95	0.48	0.00
Adipocyte - breast, donor2	11327-117E4	117.59	46.52	19.41	1.76	1.12	2.09	0.96	0.64	0.16
Adipocyte - omental, donor1	11473-119C6	145.93	47.46	29.14	3.18	1.78	3.31	1.02	0.51	0.13
Adipocyte - omental, donor2	11474-119C7	94.93	29.90	12.71	2.99	1.49	1.49	1.49	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	97.80	50.57	20.76	2.01	2.01	0.67	0.67	3.01	0.00
Adipocyte - perirenal, donor1	11476-119C9	114.84	52.95	34.45	0.64	2.55	0.00	0.64	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	72.57	42.88	16.49	0.00	0.00	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	129.16	39.74	14.00	0.45	0.45	2.71	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	63.60	34.93	7.82	1.39	0.00	0.17	1.04	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	133.18	68.65	21.71	4.69	1.37	2.15	1.56	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	93.94	50.70	12.35	2.32	0.26	2.06	0.26	1.03	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	95.90	51.02	18.68	2.79	1.12	2.23	0.56	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	103.45	57.61	16.46	5.88	0.59	1.18	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	106.09	44.96	24.69	4.99	0.88	1.61	1.29	0.88	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	74.23	45.19	11.94	5.81	1.94	2.26	2.26	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	75.71	39.99	15.46	2.67	0.53	1.07	1.07	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	112.40	47.85	15.58	4.45	2.23	0.56	1.67	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	86.51	37.01	21.63	1.66	2.08	1.66	1.25	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	75.10	33.41	13.56	2.51	2.01	1.00	1.00	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	82.14	32.07	11.78	2.29	0.33	0.65	0.98	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	61.81	20.70	13.40	4.26	1.83	2.13	1.22	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	166.85	39.12	31.16	2.43	1.33	2.21	0.66	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	89.29	50.20	34.42	0.72	0.72	1.43	1.08	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	94.64	38.34	8.39	2.40	2.40	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	124.49	49.29	10.61	1.80	1.08	0.54	0.72	0.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	95.39	40.16	8.37	1.67	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	92.66	32.46	9.25	3.08	1.03	0.62	1.44	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	85.93	36.04	3.55	8.01	0.11	0.34	0.80	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	63.43	22.04	4.65	4.41	0.49	0.00	0.98	0.24	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	103.79	79.08	31.00	4.49	1.80	1.35	2.25	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	114.61	92.04	45.58	4.34	3.47	0.87	0.00	1.30	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	126.27	94.17	36.38	0.00	2.14	6.42	4.28	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	106.42	75.93	33.48	4.18	4.18	3.29	1.79	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	101.17	65.76	37.94	5.06	2.53	2.53	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	99.01	69.31	31.68	5.28	1.98	3.96	1.32	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	98.77	70.83	30.21	3.25	3.25	2.27	1.30	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	112.14	69.42	42.72	7.28	3.88	1.94	0.97	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	86.71	61.76	32.07	2.97	2.97	1.19	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	100.94	67.04	35.40	3.39	3.77	2.64	0.75	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	113.93	62.41	31.20	2.18	2.18	1.45	0.73	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	106.57	82.75	27.58	3.76	5.02	3.76	6.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	124.87	74.30	37.72	4.12	4.78	4.45	2.97	0.16	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	111.91	69.60	24.57	1.36	1.36	4.09	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	131.19	81.73	51.57	3.32	4.83	4.52	2.11	0.30	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	96.98	80.90	37.51	3.75	1.61	2.14	1.61	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	97.68	68.58	37.98	3.02	2.65	3.02	1.51	0.19	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	100.23	76.71	29.40	3.47	4.01	2.94	2.67	0.27	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	107.30	64.38	32.19	2.93	2.93	1.95	0.98	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	84.59	62.03	35.83	2.65	1.66	2.99	1.66	0.33	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	88.85	73.24	32.42	1.20	2.40	4.80	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	134.53	63.72	24.78	0.00	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	97.60	79.93	36.36	3.60	6.00	3.43	1.72	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	138.43	58.73	25.17	0.00	4.19	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	104.85	65.53	32.04	3.88	2.43	2.43	1.46	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	89.93	53.88	37.57	5.31	3.04	2.66	1.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	89.64	88.43	23.02	4.85	2.42	3.63	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	104.32	68.40	39.33	5.13	5.70	1.71	1.14	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	102.83	71.83	27.79	4.28	3.21	2.35	1.07	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	87.49	68.91	35.10	3.87	4.65	5.68	2.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	104.63	67.10	26.28	4.69	3.75	2.35	1.41	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	113.83	78.14	39.23	1.61	3.22	4.50	1.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	96.32	54.94	32.82	1.43	2.14	7.13	2.14	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	121.08	81.31	33.93	2.34	2.92	2.34	0.00	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	99.05	74.97	39.44	5.42	3.91	1.51	1.51	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	109.30	67.72	24.95	2.38	4.75	5.94	0.00	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	92.56	69.67	40.18	6.61	1.02	3.05	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	104.17	67.24	42.02	4.84	4.33	4.33	1.78	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	94.03	61.63	39.39	4.45	4.45	1.27	4.45	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	118.24	81.13	36.25	1.29	3.02	1.29	1.73	0.43	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	96.53	72.61	27.73	4.23	4.02	1.69	0.64	0.42	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	100.33	69.60	33.35	2.03	4.35	4.64	1.74	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	104.87	73.69	50.07	0.00	4.72	2.83	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	97.82	64.93	34.41	3.39	2.71	3.22	2.03	0.00	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	106.55	85.71	57.91	6.95	2.32	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	118.30	73.94	59.15	0.00	2.11	0.00	4.23	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	88.55	66.47	34.73	3.65	4.72	2.57	1.72	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	108.30	65.58	37.90	4.21	2.41	3.61	2.41	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	100.60	80.19	30.62	2.92	1.46	0.73	2.19	2.92	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	90.34	55.17	34.02	1.84	3.22	5.52	1.38	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	117.31	73.96	43.36	5.10	2.55	2.55	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	140.84	89.49	60.76	3.81	4.32	5.08	3.31	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	101.57	78.45	40.05	3.51	4.75	4.13	1.03	0.62	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	93.33	67.63	43.15	2.45	3.06	5.20	1.22	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	100.38	87.48	42.07	6.69	1.43	3.35	0.96	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	98.90	88.03	43.24	3.77	4.66	5.10	2.00	0.89	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	99.18	76.29	41.20	7.63	0.00	1.53	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	111.33	90.84	47.63	3.88	2.77	3.88	2.22	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	106.18	78.64	45.54	3.97	3.18	4.77	2.12	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	114.85	75.60	39.98	1.82	4.00	3.27	1.45	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	84.99	31.20	9.58	4.67	0.98	0.00	0.49	0.25	0.37
Astrocyte - cerebellum, donor2	11580-120F5	76.85	30.81	12.15	1.71	1.20	0.68	1.20	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	58.31	17.83	6.71	1.26	0.21	0.63	0.63	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	93.07	36.60	11.85	15.69	1.05	1.05	1.39	0.00	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	83.80	35.27	12.29	10.84	0.65	1.94	0.97	0.00	1.29
Astrocyte - cerebral cortex, donor3	11392-118C6	112.17	35.80	18.79	6.56	0.60	1.79	0.89	0.30	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	91.75	54.13	10.21	27.07	0.46	2.06	1.03	0.46	2.41
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	92.96	52.99	12.78	19.67	0.38	2.26	1.50	0.25	1.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	94.45	47.45	10.24	27.20	0.57	2.96	1.25	0.23	1.71
Basophils, donor1	12241-129G9	26.94	209.75	8.11	1.31	25.11	17.78	32.43	3.14	0.26
Basophils, donor2	12242-129H1	62.78	199.88	10.46	3.97	16.96	18.76	35.36	1.44	0.00
Basophils, donor3	12243-129H2	37.19	261.66	12.49	0.59	28.37	12.49	47.19	4.41	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	72.44	53.47	7.33	1.72	1.08	0.22	0.86	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	79.09	63.55	13.26	0.46	1.37	0.91	1.37	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	193.69	121.95	7.17	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	62.77	25.73	10.04	1.88	0.63	0.00	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	48.87	40.34	17.26	1.66	0.83	0.00	0.42	0.62	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	103.17	36.85	18.42	3.68	0.92	0.46	0.23	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	122.72	61.18	11.52	3.42	0.18	0.54	0.54	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	57.81	323.18	16.90	11.44	8.04	8.04	16.90	1.24	1.96
Burkitt's lymphoma cell line:RAJI	10476-106I8	96.66	281.35	20.50	14.44	5.36	7.69	12.34	0.23	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	57.24	395.88	9.59	10.55	14.39	34.86	31.02	1.92	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	496.41	10.34	0.00	10.34	10.34	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	21.98	250.78	11.83	0.00	49.59	27.61	57.48	7.89	0.00
CD14+ Monocytes, donor2	11305-117B9	22.83	182.63	8.54	0.56	23.01	15.40	29.32	3.16	0.00
CD14+ Monocytes, donor3	11381-118B4	20.42	172.34	12.95	1.32	28.32	12.73	27.44	3.95	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	52.93	238.32	12.74	3.96	36.51	19.53	23.21	2.83	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	52.31	199.77	9.48	4.17	19.71	13.27	27.29	4.17	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	53.26	238.01	13.15	2.96	35.83	21.37	36.49	5.59	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	19.95	230.56	12.29	0.14	49.15	29.78	60.13	8.38	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	17.20	195.53	7.85	0.00	37.42	21.73	47.07	4.53	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	18.24	200.65	11.13	0.71	53.54	27.95	49.98	7.58	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	18.41	193.01	16.91	0.17	54.91	31.81	62.10	12.55	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	12.14	184.93	16.56	0.55	42.78	26.22	47.20	8.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	14.63	167.85	16.61	0.25	54.54	30.99	49.09	11.65	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	16.64	183.66	19.19	0.00	34.27	26.43	42.49	6.27	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	17.27	193.18	13.35	0.36	29.73	26.71	41.13	6.41	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	21.98	247.66	14.58	0.44	53.10	32.21	55.06	10.01	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	12.64	210.71	21.31	0.00	41.44	34.88	52.44	12.17	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	14.26	245.01	18.48	0.53	58.08	31.15	58.08	14.78	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	17.75	185.26	26.62	0.00	64.34	18.86	65.45	6.66	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	16.21	220.74	15.77	0.15	60.09	32.28	60.24	9.82	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	17.76	182.79	11.37	0.40	50.88	26.14	46.49	6.78	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	21.44	216.94	15.20	0.21	114.72	41.85	71.62	14.57	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	17.62	234.73	29.51	0.00	85.34	51.71	75.73	19.90	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	16.51	258.55	21.26	0.23	77.14	43.43	72.61	16.06	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	23.13	164.11	25.75	0.00	82.49	31.86	51.94	17.02	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	23.40	179.95	10.76	0.27	37.12	19.64	41.69	4.30	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	19.71	250.35	14.48	0.00	36.11	20.76	48.50	6.28	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	23.57	190.63	12.62	0.84	48.82	23.99	45.45	8.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	18.37	212.92	21.49	0.00	56.95	52.73	60.26	17.09	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	14.09	181.06	15.50	0.00	51.43	38.75	59.18	16.56	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	14.92	179.00	19.74	0.00	84.67	51.77	62.30	17.99	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	12.38	167.57	13.78	0.17	22.84	17.61	34.53	4.36	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	14.87	185.47	15.24	0.00	26.39	22.30	37.17	4.83	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	20.05	260.81	16.17	0.00	48.07	28.02	56.26	8.84	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	19.66	181.81	17.20	1.23	41.36	43.00	58.56	12.69	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	13.91	207.69	19.01	0.23	55.63	44.04	54.47	16.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	17.63	223.64	23.66	0.23	95.35	53.13	74.01	22.97	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	30.08	305.37	6.32	0.65	22.45	20.05	43.16	3.71	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	24.72	309.30	9.47	0.92	25.18	18.25	42.04	4.85	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	30.11	292.86	7.58	0.22	24.91	18.85	40.72	3.25	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	34.73	427.92	11.21	1.25	42.98	28.96	70.85	4.98	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	34.75	327.46	6.81	1.05	32.13	19.04	57.81	4.02	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	29.21	385.07	6.24	1.11	37.24	33.45	51.73	5.80	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	38.79	464.16	14.03	1.02	35.21	26.54	59.97	6.12	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	33.15	365.80	7.03	0.66	23.93	18.88	46.33	3.95	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	31.16	358.98	12.42	1.26	23.79	20.42	44.43	3.16	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	101.62	465.40	6.10	14.23	6.10	6.10	12.19	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	77.97	351.19	10.85	10.85	3.39	8.14	17.63	0.68	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	75.60	364.53	11.39	16.57	4.14	10.36	21.75	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	91.68	468.54	14.39	11.73	11.73	12.26	23.45	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	67.54	428.32	4.82	14.47	2.68	6.97	14.47	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	71.60	344.65	7.02	11.23	4.91	10.53	12.63	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	62.75	349.82	9.41	18.04	4.71	9.41	12.55	0.78	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	106.78	435.03	10.55	10.55	2.64	7.91	11.86	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	28.77	224.38	10.68	1.64	6.58	1.64	6.58	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	42.80	233.59	7.25	3.63	5.08	10.16	11.61	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	37.86	219.60	8.08	5.05	8.08	9.09	9.59	1.51	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	151.52	52.93	20.20	4.44	2.02	0.81	1.21	0.81	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	136.23	51.93	18.38	7.19	0.80	2.40	0.40	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	33.13	264.06	5.02	1.00	11.04	7.03	16.06	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	24.72	242.14	14.05	5.06	14.61	4.49	20.23	1.12	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	79.66	310.00	14.65	6.39	9.39	18.04	13.90	1.50	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	75.99	326.27	14.88	8.34	8.57	25.71	20.29	2.03	0.45
CD4+ T Cells, donor1	11225-116C1	115.33	253.51	27.85	3.93	0.71	1.79	1.79	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	103.49	240.66	20.82	2.45	1.84	4.90	1.84	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	97.90	240.03	31.11	3.96	3.96	5.49	2.13	1.22	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	125.58	141.66	9.19	11.23	0.00	0.26	0.77	0.00	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	141.05	182.37	10.78	10.33	0.45	2.02	0.45	0.00	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	133.38	184.55	9.49	10.06	0.86	1.44	0.57	0.29	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	191.53	309.11	27.50	5.69	0.47	2.84	1.42	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	181.90	372.93	14.05	7.02	0.70	2.81	1.40	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	178.00	313.14	9.89	3.30	0.00	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	151.74	192.21	22.54	14.02	0.87	4.05	1.88	0.58	1.45
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	134.38	114.73	15.08	9.66	0.00	2.71	1.69	0.17	1.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	122.84	105.43	15.48	9.19	0.48	2.90	0.97	0.16	1.45
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	160.04	182.91	16.59	7.17	2.24	4.03	0.45	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	169.80	199.15	14.32	7.69	0.00	1.75	1.05	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	141.23	151.35	11.88	12.32	0.88	2.64	0.44	0.00	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	106.68	126.91	5.90	9.28	0.84	1.26	0.42	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	108.46	193.64	12.88	10.18	0.62	3.32	2.08	0.42	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	118.62	161.72	11.69	11.36	1.00	1.34	1.34	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	137.33	383.16	19.04	9.25	0.27	2.99	1.90	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	164.00	395.53	17.15	12.33	0.00	2.68	1.61	0.00	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	129.11	312.02	14.35	5.38	1.79	1.79	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	133.14	179.31	12.05	15.39	0.19	2.04	1.48	0.00	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	125.85	165.06	19.28	12.56	0.43	3.68	2.60	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	135.34	140.59	12.40	5.88	0.21	2.31	1.47	0.21	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	140.56	279.60	18.71	8.09	2.02	2.02	0.51	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	157.27	280.31	22.96	10.40	1.30	2.60	0.87	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	130.74	237.95	15.69	7.41	0.44	3.05	0.87	0.00	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	173.20	334.53	12.87	11.88	1.48	3.46	1.48	0.49	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	143.09	300.96	10.16	5.54	0.00	0.92	0.92	0.00	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	205.19	312.66	27.92	8.37	1.40	1.40	1.40	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	129.05	282.47	8.58	7.75	4.15	1.11	6.37	1.11	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	140.85	292.75	11.29	17.18	1.96	0.25	5.15	0.25	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	166.32	235.62	7.70	13.86	7.70	4.62	4.62	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	156.86	285.42	12.89	12.18	5.37	5.01	10.39	0.72	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	191.13	278.38	11.08	8.31	2.77	4.15	4.15	1.38	1.38
CD8+ T Cells, donor1	11226-116C2	126.37	224.59	38.96	5.57	4.58	6.55	1.96	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	89.35	127.27	28.16	3.38	2.25	5.26	4.13	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	110.34	186.59	27.52	4.04	0.76	2.52	2.52	0.25	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	124.10	90.61	35.56	1.15	1.38	4.13	2.29	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	119.10	100.17	29.24	0.24	0.72	2.88	2.40	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	121.75	96.03	36.11	1.64	1.64	4.38	2.46	0.27	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	129.69	79.56	30.02	3.30	1.80	3.90	3.00	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	117.83	101.99	32.16	1.92	0.48	4.08	2.16	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	111.19	92.77	27.74	3.41	1.59	3.87	0.68	0.45	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	96.26	80.83	30.64	1.74	1.30	1.96	2.39	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	91.07	85.54	31.32	1.05	0.79	1.84	1.84	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	105.53	82.08	34.71	1.64	0.70	3.99	1.41	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	107.47	116.83	40.15	1.21	2.11	5.13	3.02	1.21	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	100.81	104.58	36.31	2.03	2.61	5.23	1.45	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	92.19	105.51	30.11	2.13	2.13	4.00	1.60	0.80	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	63.91	89.30	26.27	4.38	13.57	3.50	0.88	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	55.56	81.98	23.68	1.82	8.65	3.19	2.73	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	55.19	83.54	16.41	2.98	8.20	3.73	3.73	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	107.33	73.83	24.85	2.52	0.36	0.72	1.08	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	100.13	75.10	32.22	2.01	2.01	4.03	0.58	0.29	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	90.04	75.89	21.92	2.83	2.36	3.06	1.41	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	95.07	82.08	26.94	0.95	1.58	4.75	1.90	0.32	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	108.26	98.11	28.30	1.85	2.77	6.77	1.54	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	91.37	80.79	29.81	2.89	2.89	4.17	1.92	0.32	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	100.59	93.32	29.07	2.68	1.15	4.21	2.29	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	100.10	108.38	30.74	3.55	1.58	3.15	0.39	0.39	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	96.06	97.58	27.99	3.03	1.51	5.29	2.27	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	93.14	60.22	39.34	15.26	6.42	5.62	1.61	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	78.34	83.93	48.26	13.99	9.79	2.10	2.80	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	77.13	81.14	28.05	13.02	8.01	2.00	1.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	74.94	32.90	12.79	3.66	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	92.89	38.04	10.38	1.48	0.49	0.99	0.99	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	129.96	68.30	13.26	0.63	0.74	2.10	1.26	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	128.27	50.61	25.65	3.12	0.69	0.35	0.35	1.39	0.00
Chondrocyte - de diff, donor2	11338-117F6	57.57	23.81	7.82	0.71	1.07	0.00	0.71	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	87.15	58.03	11.38	2.05	1.14	1.59	1.25	0.57	0.11
Chondrocyte - re diff, donor2	11339-117F7	163.83	39.39	16.11	1.79	0.90	2.69	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	162.17	80.07	20.22	1.21	3.24	4.04	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	86.30	38.21	8.72	8.95	1.38	0.80	0.57	0.00	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	101.32	37.84	16.89	4.49	0.64	1.71	0.86	0.43	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	113.81	42.12	12.92	3.63	1.68	1.50	0.88	0.18	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	96.74	47.50	15.13	7.61	4.13	3.39	3.21	0.37	0.64
Corneal Epithelial Cells, donor1	11526-119I5	86.95	50.28	7.47	1.10	0.88	0.88	0.66	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	45.50	28.44	5.69	2.28	0.00	1.14	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	77.20	39.37	7.41	1.53	0.51	1.28	0.51	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	62.90	197.45	26.42	4.62	36.82	27.24	26.25	4.46	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	64.34	201.23	23.97	4.42	27.76	29.33	18.92	2.84	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	86.27	217.39	17.25	3.45	13.80	44.86	34.51	17.25	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	48.92	121.81	18.25	2.16	21.17	20.73	10.26	1.94	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	46.12	375.46	9.57	4.44	15.37	10.59	9.57	2.39	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	37.21	404.78	11.75	4.57	13.06	15.67	11.75	2.61	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	32.42	336.83	15.49	5.32	9.68	5.81	12.58	1.94	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	52.70	94.06	13.68	2.00	3.84	12.17	1.83	1.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	52.81	56.92	8.80	1.17	2.93	4.69	1.76	1.76	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	75.22	85.40	14.42	1.41	1.13	6.22	4.52	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	45.61	62.12	8.65	1.18	3.54	7.47	2.75	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	53.81	67.48	13.67	0.58	6.11	7.85	4.07	0.87	0.29
Endothelial Cells - Artery, donor2	11341-117F9	69.88	100.23	18.12	0.24	5.65	14.82	5.88	1.41	0.24
Endothelial Cells - Artery, donor3	11413-118E9	66.97	80.99	19.46	0.88	3.51	11.92	2.63	0.70	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	57.63	70.26	5.54	2.22	1.55	3.32	2.22	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	74.55	62.68	8.52	1.52	3.96	4.26	3.35	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	65.97	62.58	5.64	0.85	2.82	5.92	3.38	1.41	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	31.20	61.80	5.94	1.19	1.19	0.59	3.27	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	65.08	64.56	7.81	1.04	3.12	9.37	5.21	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	24.67	60.54	1.28	1.28	2.27	3.12	2.55	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	77.22	99.23	19.61	0.80	2.80	3.20	4.00	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	65.52	72.33	9.96	0.00	4.19	11.01	4.19	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	80.39	122.88	9.32	4.97	3.35	8.70	6.09	0.37	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	51.93	87.99	7.39	2.39	2.39	8.04	1.96	0.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	72.42	96.60	9.65	2.20	2.81	11.85	3.54	0.24	0.37
Endothelial Cells - Vein, donor1	11267-116G7	51.19	44.36	15.93	0.00	3.41	12.51	2.28	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	62.87	95.00	13.27	0.00	4.19	13.27	3.49	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	60.45	83.21	11.78	0.16	3.93	9.42	3.14	1.10	0.00
Eosinophils, donor1	12244-129H3	91.48	350.68	45.74	0.00	0.00	15.25	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	46.21	488.48	23.10	0.00	432.37	176.58	186.48	36.31	0.00
Eosinophils, donor3	12246-129H5	64.20	449.42	21.40	0.00	285.35	156.94	153.37	35.67	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	80.87	58.15	8.31	1.95	0.98	0.49	0.00	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	62.40	52.00	8.32	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	244.03	113.88	48.81	0.00	0.00	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	125.21	58.70	22.58	0.00	4.52	3.28	0.82	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	100.40	50.69	40.62	1.75	3.94	3.72	2.41	0.99	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	154.38	51.24	26.11	1.95	2.06	2.71	1.73	0.54	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	133.29	59.31	26.68	1.70	2.67	3.03	2.06	0.49	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	98.94	28.39	34.12	7.92	6.14	4.50	1.36	0.00	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	118.55	51.36	25.00	2.64	1.27	2.95	1.27	0.74	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	57.97	12.65	20.29	7.64	0.53	0.00	0.00	0.00	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	118.26	44.51	26.24	1.33	1.66	2.66	1.33	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	90.73	47.63	22.23	1.36	1.36	2.27	1.81	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	129.61	97.02	41.69	0.76	1.52	3.79	1.52	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	98.26	56.15	25.23	1.42	2.21	4.89	2.21	0.16	0.16
Fibroblast - Cardiac, donor4	11452-119A3	114.88	50.92	14.85	3.33	1.21	0.61	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	94.04	65.86	18.27	1.78	0.89	1.52	1.65	0.25	0.13
Fibroblast - Cardiac, donor6	11460-119B2	85.35	52.30	17.58	1.67	1.52	1.52	1.52	0.30	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	156.90	57.75	24.25	1.21	0.80	0.40	0.80	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	165.24	60.40	22.87	0.00	0.43	3.45	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	161.13	67.38	20.51	2.93	4.39	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	199.73	53.28	16.38	3.46	0.46	0.92	0.69	0.00	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	113.63	51.22	5.09	7.80	0.34	0.68	0.68	0.00	1.02
Fibroblast - Dermal, donor1	11269-116G9	104.24	38.74	15.50	0.47	0.94	0.23	0.70	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	102.35	44.81	16.98	0.00	0.94	2.36	1.42	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	113.15	56.94	12.21	0.85	1.21	1.69	0.85	0.00	0.12
Fibroblast - Dermal, donor4	11450-119A1	128.31	36.97	14.47	4.07	0.23	0.45	0.57	0.11	0.11
Fibroblast - Dermal, donor5	11454-119A5	134.15	46.06	18.49	3.66	0.87	0.52	0.35	0.35	0.52
Fibroblast - Dermal, donor6	11458-119A9	166.48	40.93	26.96	2.27	0.32	0.81	0.49	0.32	0.32
Fibroblast - Gingival, donor1	11237-116D4	133.89	45.39	14.58	4.79	1.25	0.42	0.83	0.42	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	145.93	57.12	24.10	2.62	0.79	2.10	1.31	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	155.90	44.02	14.76	4.61	0.40	1.19	1.05	0.13	0.53
Fibroblast - Gingival, donor3	11394-118C8	104.13	44.77	7.93	4.83	0.19	0.68	0.77	0.10	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	122.59	40.52	19.74	3.12	0.00	1.04	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	113.30	42.82	15.51	1.76	0.53	1.59	0.53	0.35	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	147.01	46.46	27.28	4.37	1.09	2.96	1.56	0.31	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	129.82	37.59	19.88	2.70	0.54	1.22	0.81	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	84.69	35.64	15.53	0.71	1.76	1.41	1.06	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	149.02	53.96	22.81	2.92	1.61	1.90	0.73	0.00	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	140.58	47.45	21.82	3.82	1.36	1.50	0.41	0.41	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	145.56	58.69	30.39	1.10	1.32	2.30	0.99	0.22	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	163.03	79.53	25.68	3.67	1.17	1.91	1.17	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	46.22	14.95	2.72	0.00	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	86.54	28.35	4.48	7.46	0.00	0.00	1.49	0.00	2.98
Fibroblast - Lung, donor3	11419-118F6	99.40	34.61	8.44	1.27	0.21	1.06	0.63	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	219.92	56.65	31.65	0.83	0.83	2.50	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	102.10	26.57	19.58	1.40	0.00	1.40	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	92.08	36.94	10.64	0.56	0.56	1.40	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	241.15	60.49	26.79	0.81	0.81	2.84	1.22	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	159.77	47.93	23.97	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	125.08	71.48	29.78	0.00	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	192.42	56.45	19.20	4.27	0.19	0.58	1.55	0.19	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	160.78	45.20	15.77	3.34	0.15	1.21	0.30	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	160.03	44.67	20.50	2.14	0.92	1.22	0.31	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	116.40	32.82	10.69	0.76	0.38	0.38	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	126.90	40.23	20.79	1.62	1.35	2.70	1.08	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	102.17	49.29	14.03	0.93	1.16	1.62	0.93	0.93	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	165.58	71.07	32.61	0.55	2.43	5.42	1.77	0.88	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	235.50	53.85	27.43	1.63	1.02	0.41	0.61	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	91.54	30.07	8.69	0.00	0.00	0.00	0.67	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	127.70	47.44	11.47	0.79	0.79	0.79	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	81.56	20.64	18.06	1.19	0.00	0.40	0.60	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	129.66	51.15	13.50	3.37	0.71	0.89	0.71	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	129.68	65.83	16.75	2.96	0.39	0.99	0.99	0.39	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	74.01	21.06	21.36	1.20	0.30	0.60	0.30	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	109.68	52.90	25.48	3.02	1.08	0.65	0.97	0.11	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	89.08	16.45	14.17	1.77	1.27	0.76	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	135.86	43.15	11.32	2.13	0.66	1.15	0.66	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	90.03	19.05	14.84	2.61	0.20	1.60	0.20	0.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	116.94	37.87	19.59	1.71	1.21	0.60	0.40	0.30	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	90.67	17.83	16.02	3.93	0.30	0.00	0.00	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	137.44	66.94	14.83	3.15	0.66	0.83	0.75	0.17	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	116.93	66.33	12.65	8.72	0.17	0.34	1.37	0.17	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	84.41	22.00	14.78	3.61	0.99	0.99	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	119.30	40.27	23.65	2.56	1.70	0.96	0.85	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	133.09	34.58	14.68	3.37	0.51	0.67	0.67	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	101.15	30.89	10.98	2.20	1.10	1.57	1.10	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	44.32	0.00	44.32	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	95.87	43.58	13.07	6.97	2.61	0.87	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	105.05	67.96	31.55	4.33	4.33	3.12	1.04	0.00	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	130.12	67.40	36.17	4.68	5.20	5.20	1.56	0.78	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	88.15	39.60	29.38	3.32	3.07	0.77	0.51	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	147.75	104.88	35.22	6.12	4.59	3.83	5.36	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	165.26	93.80	46.58	4.47	4.47	4.47	3.83	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	178.86	73.31	27.10	12.84	4.85	3.99	3.71	0.29	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	102.86	36.95	8.27	9.65	2.48	0.28	2.76	0.00	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	80.60	33.34	10.05	11.42	0.91	1.60	3.88	0.23	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	142.85	61.82	29.92	6.93	2.18	2.38	2.38	0.79	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	93.05	42.56	8.19	8.99	0.00	1.06	2.91	0.53	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	76.97	28.37	7.83	14.02	1.63	1.96	4.57	0.00	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	171.14	93.75	31.84	17.25	3.98	1.77	4.86	0.44	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	134.96	69.11	19.79	7.49	1.55	0.85	1.70	0.14	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	125.48	70.68	18.96	6.28	2.34	1.48	1.85	0.00	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	113.90	54.80	17.73	3.76	1.34	2.15	2.69	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	111.75	66.78	14.99	6.69	0.99	1.86	1.12	0.12	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	108.53	63.54	15.09	8.17	0.55	0.83	1.11	0.00	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	102.87	45.95	14.03	7.52	0.61	1.83	0.81	0.20	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	106.10	68.68	14.38	7.53	1.37	1.60	1.14	0.46	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	96.41	63.65	10.09	6.35	0.87	1.00	1.37	0.25	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	105.79	60.98	14.43	6.99	0.87	1.09	1.75	0.00	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	107.26	69.73	16.55	7.98	0.89	1.18	0.59	1.18	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	108.41	67.72	13.83	6.84	1.59	0.79	0.79	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	113.05	58.76	14.08	3.57	1.12	0.89	2.68	0.22	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	101.82	53.84	8.27	7.26	0.40	0.81	0.81	0.40	2.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	103.82	62.09	11.87	8.82	0.00	1.87	1.02	0.00	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	138.95	77.41	16.32	7.09	1.33	2.22	1.68	0.18	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	138.19	87.93	9.78	6.04	0.52	1.35	1.14	0.73	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	129.11	79.24	8.71	6.49	0.68	1.20	2.73	0.51	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	99.04	49.02	11.84	5.09	0.22	0.55	0.55	0.33	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	133.70	74.88	18.97	7.15	1.41	1.75	1.83	0.75	1.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	120.67	61.25	13.88	7.15	1.84	2.04	1.23	0.41	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	113.06	55.08	9.28	6.19	0.41	1.65	0.62	0.41	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	111.95	68.25	10.38	5.30	0.58	0.23	0.46	0.12	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	88.55	51.86	11.51	5.50	0.33	1.33	1.33	0.17	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	94.34	60.18	11.46	4.85	0.88	1.10	1.10	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	119.67	73.43	13.41	7.26	0.86	1.48	1.23	0.37	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	103.58	42.31	10.37	7.13	0.65	0.97	1.46	0.16	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	124.76	89.48	12.19	7.38	0.64	0.00	0.32	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	84.43	48.61	7.86	2.94	0.95	0.57	0.85	0.09	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	83.36	58.84	10.76	2.21	0.47	0.32	1.42	0.47	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	91.53	40.75	7.30	6.08	0.00	0.30	0.30	0.30	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	91.37	43.17	9.93	4.18	0.42	0.63	0.63	0.10	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	93.53	55.77	9.44	4.83	0.44	1.10	0.88	0.00	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	85.01	54.99	7.86	3.37	0.56	1.96	1.12	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	67.87	29.81	8.52	3.15	0.83	0.56	0.56	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	94.66	28.34	7.22	4.55	1.07	1.34	0.80	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	91.04	33.05	9.49	3.21	1.07	1.22	1.22	0.15	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	98.97	41.06	13.34	2.46	0.52	0.91	1.04	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	94.06	45.54	8.95	4.88	0.00	0.81	1.08	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	102.50	42.77	9.22	3.87	0.74	1.47	0.74	0.55	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	107.90	43.42	10.97	3.29	0.88	0.88	0.66	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	86.28	29.75	11.90	5.95	0.00	0.00	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	128.22	54.08	15.43	1.98	0.79	1.32	0.66	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	125.49	48.02	16.14	3.43	0.61	1.82	0.40	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	112.59	46.77	9.15	6.86	0.00	0.51	1.02	0.25	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	119.64	73.65	23.49	9.75	1.19	0.40	1.59	0.00	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	130.50	65.79	18.03	5.24	1.23	0.77	0.92	0.31	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	153.03	76.31	21.07	9.00	1.84	0.61	1.43	0.41	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	185.57	70.41	43.81	6.26	2.19	4.07	3.44	0.31	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	184.23	79.12	41.82	5.93	2.54	1.70	1.70	0.00	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	136.06	59.50	20.75	15.68	0.92	0.00	3.23	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	131.16	81.67	29.70	22.27	2.47	0.00	9.90	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	149.31	61.50	28.24	11.99	3.87	3.48	4.25	0.77	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	170.07	72.20	49.74	11.23	0.00	3.21	3.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	126.93	50.43	20.87	15.65	0.00	0.00	1.74	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	140.61	49.15	29.29	11.39	1.63	1.63	1.30	0.65	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	144.54	53.53	22.65	16.06	2.88	2.88	4.12	0.41	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	133.29	59.98	36.65	10.00	0.00	3.33	10.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	143.74	49.22	26.01	12.02	2.24	1.40	1.12	0.28	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	153.94	56.54	29.74	8.82	1.96	0.98	3.60	0.00	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	109.89	43.62	19.29	5.03	0.84	0.84	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	164.44	60.75	19.72	13.04	1.27	0.64	2.54	0.32	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	161.00	56.72	20.72	7.47	0.68	2.04	1.36	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	160.79	43.85	10.44	8.35	0.00	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	172.38	56.12	11.45	8.59	0.00	2.29	1.72	0.57	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	135.56	51.21	17.46	5.33	0.89	0.59	0.59	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	155.86	71.15	20.33	5.08	1.69	0.00	5.08	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	158.64	62.13	24.85	12.01	0.83	2.90	2.07	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	124.73	55.00	22.09	13.12	2.07	1.15	3.45	0.23	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	184.40	89.56	21.07	15.81	5.27	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	118.01	64.97	18.45	13.45	1.15	0.38	3.46	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	153.86	64.54	22.82	11.41	2.28	0.33	3.26	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	156.51	82.94	18.06	8.03	3.34	0.00	3.34	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	169.13	80.52	14.64	11.56	1.16	1.54	1.54	0.39	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	193.42	79.42	46.22	14.04	2.40	3.08	3.77	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	139.15	89.45	17.39	14.91	2.48	2.48	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	195.35	101.92	14.63	11.32	0.47	1.42	1.89	0.94	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	175.62	79.66	19.92	7.24	1.21	0.00	3.02	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	186.18	72.23	20.35	16.28	1.02	2.54	2.03	1.53	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	155.95	94.92	19.54	10.77	1.99	0.80	1.99	0.00	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	185.50	88.31	15.29	11.35	0.49	1.48	1.97	0.99	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	219.56	96.80	24.79	9.44	0.00	2.36	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	167.45	124.86	14.00	15.17	0.00	0.00	2.33	0.00	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	239.63	109.72	35.55	14.92	2.19	1.76	2.63	0.44	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	108.50	66.97	16.11	6.78	0.85	3.39	1.70	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	95.51	45.96	20.30	5.97	0.60	2.39	0.60	0.00	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	102.39	50.95	19.41	10.68	2.43	0.00	0.49	0.00	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	112.99	38.80	25.11	1.14	0.00	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	106.86	45.32	15.80	0.83	0.83	1.66	1.66	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	158.55	42.73	24.74	0.00	2.25	4.50	3.37	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	78.34	45.67	8.25	3.81	0.32	0.00	1.90	0.00	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	63.91	38.85	7.94	1.67	1.67	0.00	0.42	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	69.39	48.04	14.85	2.55	1.28	1.51	0.93	0.23	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	64.31	48.11	17.22	2.36	1.69	2.19	1.35	0.17	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	66.89	43.23	18.43	2.05	1.14	1.59	0.91	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	71.27	49.41	18.69	2.40	1.75	1.75	1.42	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	68.56	39.54	13.97	2.79	0.86	1.07	1.93	0.00	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	60.71	45.64	15.50	2.37	1.51	1.29	1.51	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	68.99	54.55	21.54	2.37	1.99	1.25	1.25	0.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	59.18	45.80	17.33	1.72	0.69	2.06	1.37	0.51	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	54.46	49.02	19.54	1.92	0.96	2.56	0.96	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	40.85	47.01	5.60	0.00	1.12	1.68	1.68	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	105.60	73.14	12.12	0.00	1.73	1.30	3.90	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	105.75	81.96	2.64	2.64	2.64	5.29	7.93	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	173.19	51.50	16.93	1.06	0.71	0.71	0.71	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	114.06	51.58	13.80	0.00	2.18	1.45	2.18	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	131.65	59.10	27.10	1.05	2.45	3.15	1.57	0.17	0.00
Hepatocyte, donor1	11523-119I2	254.23	93.22	49.63	6.05	2.42	1.21	2.42	1.21	0.00
Hepatocyte, donor2	11603-120I1	197.15	88.34	48.48	4.31	5.39	4.31	2.15	0.00	1.08
Hepatocyte, donor3	11684-122I1	191.42	56.45	50.92	4.29	3.68	5.52	3.07	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	128.58	91.38	31.98	16.97	4.57	5.22	0.00	0.65	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	137.38	82.32	26.74	12.23	5.42	2.80	1.92	0.52	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	103.87	41.57	14.13	2.20	1.23	0.27	0.96	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	82.78	25.47	15.92	9.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	153.53	53.40	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	189.58	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	119.06	34.61	20.77	8.31	0.00	0.00	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	105.11	27.53	17.52	5.01	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	118.68	47.47	35.60	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	99.95	28.19	10.25	7.69	0.00	2.56	5.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	118.84	45.71	22.85	0.00	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	116.95	56.85	24.36	6.50	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	110.04	30.01	8.34	5.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	105.29	43.57	14.52	0.00	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	127.05	43.67	26.47	0.00	1.32	0.00	0.00	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	114.19	45.45	14.41	0.00	1.11	0.00	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	89.05	68.10	15.71	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	138.57	43.46	18.90	5.67	1.26	1.26	0.63	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	86.61	23.20	10.83	3.09	0.00	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	29.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	104.01	28.43	15.50	3.88	0.00	0.65	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	91.77	37.03	16.10	3.22	0.00	0.00	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	23.90	35.84	0.00	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	124.68	36.67	17.93	4.89	0.81	4.07	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	123.84	31.91	11.33	2.10	1.26	2.10	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	100.61	43.12	0.00	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	122.16	37.77	19.29	1.61	0.00	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	117.26	42.47	15.70	0.92	0.00	0.92	1.85	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	45.24	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	111.87	44.37	22.19	2.83	0.94	2.36	0.47	0.47	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	85.26	33.56	9.98	3.63	0.91	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	109.76	71.02	16.14	3.23	1.08	0.00	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	123.23	35.57	22.87	3.81	1.27	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	147.87	49.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	112.23	37.62	16.58	2.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	92.96	27.34	14.58	0.00	1.82	1.82	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	31.61	31.61	0.00	0.00	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	118.53	37.85	17.14	4.28	0.71	0.00	1.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	86.28	23.23	13.27	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	112.66	46.61	15.43	3.40	0.62	0.31	0.62	0.00	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	91.31	38.63	12.29	1.76	0.00	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	88.01	31.43	15.72	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	87.62	41.72	18.08	4.17	2.09	2.09	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	97.38	17.70	15.49	2.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	123.20	64.84	22.69	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	101.14	41.85	15.69	3.49	0.00	2.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	107.99	18.00	24.75	0.00	0.00	0.00	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	90.60	20.91	20.91	3.48	0.00	0.00	3.48	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	122.68	45.87	7.47	0.00	0.00	0.00	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	77.58	30.48	15.24	1.39	0.00	1.39	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	94.04	14.25	17.10	0.00	0.00	5.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	102.17	23.93	9.20	1.84	0.00	2.76	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	81.68	48.41	6.05	0.00	0.00	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	173.84	49.67	31.04	0.00	0.00	6.21	0.00	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	94.11	42.29	6.34	0.00	2.11	2.11	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	85.11	37.62	16.40	3.35	0.98	1.06	0.49	0.49	0.41
Keratinocyte - epidermal, donor2	11349-117G8	96.63	35.72	14.06	0.59	0.00	0.00	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	150.60	58.50	25.75	3.03	0.95	1.61	0.47	0.09	0.19
Keratinocyte - oral, donor1	11251-116E9	139.63	84.34	9.76	6.81	0.79	0.23	1.14	0.00	1.14
Keratocytes, donor1	11527-119I6	331.11	69.80	28.88	1.72	0.69	0.34	1.72	0.00	0.34
Keratocytes, donor2	11607-120I5	128.90	30.47	14.06	1.17	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	178.23	72.52	14.23	2.57	0.20	0.40	0.59	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	101.10	68.14	8.79	10.99	15.39	2.20	4.40	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	89.54	39.91	17.26	1.08	2.16	1.08	0.00	0.00	2.16
Lens Epithelial Cells, donor2	11609-120I7	65.97	29.52	4.50	4.96	0.12	0.35	0.81	0.12	0.35
Lens Epithelial Cells, donor3	11690-122I7	161.35	67.61	27.35	3.73	3.13	2.83	0.81	0.10	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	47.19	63.56	7.35	2.13	2.37	4.15	2.96	0.47	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	30.14	70.33	4.19	1.12	1.40	1.95	3.63	0.84	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	47.07	69.89	6.14	3.46	1.57	6.61	3.78	0.63	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	37.10	61.30	4.84	0.54	1.08	2.69	1.61	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	40.03	61.14	4.73	1.26	2.84	4.73	2.52	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	30.30	61.13	6.04	1.62	1.94	5.28	3.99	0.32	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	46.37	62.79	3.69	1.64	2.46	4.10	4.92	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	25.28	72.31	5.06	0.25	2.02	2.53	6.32	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	28.01	56.16	3.94	1.97	2.53	2.39	3.52	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	36.78	56.17	3.56	2.77	1.98	3.16	1.98	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	40.52	75.23	5.62	1.74	2.13	4.27	4.46	0.58	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	28.14	59.62	3.52	0.93	2.78	3.33	4.63	0.37	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	37.28	65.50	3.14	2.09	1.74	3.14	2.09	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	34.82	75.61	5.25	0.72	1.91	4.77	4.77	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	33.51	66.61	4.81	1.37	1.65	4.81	3.57	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	35.11	69.29	6.47	2.16	0.92	4.00	2.77	0.92	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	27.75	74.20	5.61	1.25	2.18	4.36	3.74	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	33.85	66.24	5.12	1.46	1.65	4.39	4.57	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	41.47	66.15	6.58	2.63	1.65	3.62	3.95	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	31.92	72.93	4.69	0.59	2.64	4.10	3.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	30.62	59.00	4.73	0.75	1.99	3.49	2.74	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	47.53	60.14	6.30	4.85	0.97	5.82	3.88	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	38.24	68.67	8.35	2.15	1.89	4.31	3.77	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	39.06	57.07	5.90	3.03	2.27	4.69	4.24	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	45.62	66.88	5.18	4.15	1.56	2.59	0.52	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	41.04	77.06	8.59	0.42	1.26	3.14	2.09	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	30.22	63.91	5.11	1.05	1.80	3.91	2.71	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	46.78	63.28	11.69	2.75	2.06	5.50	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	36.31	66.98	5.46	0.56	2.26	2.82	4.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	26.51	56.83	4.98	1.48	2.65	3.18	3.29	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	42.16	60.09	9.69	1.45	1.45	1.45	1.94	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	33.41	73.77	3.97	0.33	1.32	1.98	3.31	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	27.38	59.34	4.46	1.73	2.11	3.10	2.97	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	45.54	57.75	7.03	2.22	2.96	4.07	2.22	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	36.82	70.67	5.68	0.74	1.98	5.93	4.69	0.49	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	30.39	58.02	2.61	2.20	1.51	3.71	3.99	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	35.70	62.40	9.33	1.93	1.29	4.50	2.57	0.96	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	45.95	73.95	8.52	1.83	2.74	4.26	5.78	0.91	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	36.81	69.00	4.62	2.94	2.24	4.90	3.22	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	41.25	65.78	6.76	4.62	1.07	4.27	1.78	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	32.48	63.99	2.42	0.97	0.97	5.82	2.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	29.10	60.22	3.58	0.47	2.80	4.51	4.20	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	51.57	72.70	7.52	1.79	2.51	5.01	2.51	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	33.65	72.20	4.25	0.98	0.98	3.59	1.96	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	30.13	58.15	3.77	0.71	1.65	1.88	2.59	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	53.46	65.96	7.30	3.47	1.73	4.70	3.22	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	32.53	66.34	5.63	0.26	2.82	0.77	3.84	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	26.55	59.37	5.07	1.49	2.69	2.69	2.39	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	142.76	86.11	31.72	6.80	4.53	4.53	2.27	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	131.18	60.60	28.38	3.84	3.07	0.00	1.53	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	115.05	61.60	25.24	5.94	2.23	2.97	2.97	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	121.01	70.24	29.20	8.89	3.81	2.12	1.69	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	121.67	83.70	31.65	3.52	4.22	2.81	0.70	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	143.83	74.72	32.69	3.74	4.67	0.00	0.93	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	120.57	56.68	20.61	8.24	3.61	1.03	1.55	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	124.89	58.28	24.98	5.95	3.57	2.38	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	134.58	89.12	21.94	7.69	3.17	3.62	2.71	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	135.53	77.65	24.14	9.89	3.49	2.04	1.45	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	142.26	81.48	36.91	7.20	3.60	1.35	1.80	2.25	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	156.22	91.18	24.93	7.86	2.85	3.66	2.71	0.54	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	125.81	76.00	24.65	5.14	2.05	2.05	3.08	0.51	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	141.14	86.10	30.70	6.35	1.76	3.18	2.47	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	123.93	83.29	29.32	6.66	1.33	0.00	2.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	137.02	69.79	29.03	7.13	3.57	1.02	2.04	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	146.21	78.17	30.68	8.54	2.40	2.93	2.40	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	129.81	82.76	33.63	7.75	3.40	2.65	2.46	0.94	1.51
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	142.96	63.20	23.93	12.27	1.23	1.84	1.23	0.00	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	167.16	89.70	27.72	3.26	4.08	3.26	1.63	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	131.40	83.71	26.45	9.37	3.75	3.54	3.12	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	129.76	67.26	18.50	10.93	3.36	1.40	1.68	0.28	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	133.94	87.58	40.18	12.36	2.06	1.03	1.03	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	144.57	84.77	31.06	7.26	1.45	2.90	1.74	0.29	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	132.43	66.36	24.51	9.27	2.39	3.59	2.39	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	134.44	78.01	23.79	9.96	2.21	2.21	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	136.09	90.85	26.51	5.30	3.18	2.83	2.47	0.71	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	143.46	78.55	27.66	6.64	2.58	2.95	2.95	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	132.40	63.32	24.18	5.76	3.45	1.15	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	137.00	84.43	30.70	10.36	3.84	3.84	2.30	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	123.98	66.80	16.98	8.49	3.40	3.96	2.26	0.00	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	127.99	79.59	31.18	3.28	2.46	1.64	2.46	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	121.10	81.34	30.28	6.78	1.81	1.36	2.71	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	127.83	51.71	23.70	12.93	3.59	1.44	2.87	0.00	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	135.19	82.91	27.64	8.96	2.24	2.99	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	114.45	80.26	26.01	10.78	3.34	2.23	2.23	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	117.59	70.21	26.28	9.05	3.45	0.86	1.72	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	135.30	75.35	34.25	8.56	4.28	3.43	2.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	134.27	79.96	33.32	6.00	3.00	2.00	1.67	0.00	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	130.31	65.16	17.50	9.05	3.62	2.41	1.81	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	120.16	61.15	27.02	6.40	0.71	0.00	0.71	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	110.33	73.56	30.25	3.78	3.09	1.37	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	106.81	61.73	18.79	4.83	2.68	2.68	2.15	0.54	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	116.49	79.46	26.26	2.02	3.37	0.00	1.35	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	125.94	79.27	25.56	5.93	1.85	2.22	3.33	0.37	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	130.25	111.64	24.42	10.47	4.65	2.33	2.33	0.00	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	133.28	75.10	28.56	10.58	2.12	1.06	4.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	120.05	83.23	24.01	4.80	1.60	1.20	0.40	0.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	133.02	63.24	31.26	9.45	2.91	2.91	4.36	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	134.91	66.69	29.89	6.90	8.43	4.60	3.07	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	124.80	90.76	23.68	9.37	2.96	4.44	2.47	0.00	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	121.38	74.33	24.46	6.59	3.76	2.82	0.94	0.00	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	153.86	88.50	29.67	5.03	3.52	2.51	1.51	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	136.09	75.70	27.49	4.96	3.15	3.15	3.15	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	106.71	49.91	22.37	10.33	6.88	0.00	3.44	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	142.06	81.94	27.17	7.57	5.34	0.89	2.23	1.34	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	147.42	84.46	30.11	7.43	1.96	3.52	3.13	0.00	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	123.37	62.02	22.43	7.92	2.64	2.64	1.32	0.00	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	143.22	90.29	26.98	6.75	3.63	2.59	2.08	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	154.90	86.20	35.88	6.13	3.06	2.19	2.63	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	112.94	68.77	21.25	7.83	3.35	2.24	2.24	0.56	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	140.88	93.63	37.54	6.18	3.97	1.32	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	137.31	87.94	32.79	8.49	2.31	1.93	1.93	1.54	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	148.36	62.79	28.36	4.05	5.06	1.52	0.51	0.00	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	136.98	76.90	37.01	4.81	2.40	1.92	3.36	0.00	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	144.71	80.30	31.01	7.16	1.19	3.58	1.19	0.80	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	137.32	65.62	29.77	6.08	3.65	1.22	1.22	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	113.44	74.70	42.19	7.61	1.38	1.38	2.08	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	136.04	81.70	28.88	7.98	2.66	2.66	0.76	0.38	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	149.24	68.68	27.37	6.20	2.07	0.52	1.03	0.00	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	137.86	71.35	48.37	5.44	2.42	0.00	0.60	1.81	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	132.78	79.54	30.42	6.34	1.90	2.54	0.95	0.63	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	184.45	76.23	29.32	6.40	4.80	3.20	2.13	0.53	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	124.70	73.56	50.57	4.60	1.72	0.57	3.45	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	150.67	85.36	31.37	6.17	3.09	2.57	1.54	0.00	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	150.67	76.39	33.95	7.78	2.83	1.41	1.41	0.71	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	145.84	83.42	42.56	7.94	4.54	0.57	1.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	152.27	94.85	34.11	6.24	2.08	3.33	1.25	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	148.78	68.91	28.19	10.18	3.92	3.13	3.92	0.00	4.70
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	139.04	79.75	43.84	8.77	2.09	0.42	0.84	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	166.80	96.18	41.82	6.97	1.39	3.72	0.46	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	154.55	66.24	30.78	12.04	2.01	2.68	2.01	0.00	4.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	150.77	87.15	52.39	6.42	2.14	0.00	1.60	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	159.21	89.71	38.39	8.89	2.42	2.83	3.64	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	158.77	65.16	33.96	11.93	0.00	1.84	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	136.92	65.79	57.79	7.11	1.78	0.00	3.56	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	169.82	73.51	45.02	6.84	2.28	0.57	2.28	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	151.08	62.89	21.47	9.20	2.30	0.77	0.00	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	132.42	78.25	45.42	10.40	1.09	0.00	0.00	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	146.11	77.51	36.97	5.79	3.56	2.23	2.23	1.78	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	191.59	89.16	37.43	6.24	4.16	3.38	3.12	0.52	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	172.41	74.27	51.06	12.60	3.32	0.66	1.33	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	178.76	78.99	29.10	8.31	2.08	2.08	4.16	0.00	4.16
Macrophage - monocyte derived, donor1	11232-116C8	47.63	111.91	6.15	1.14	21.65	12.54	11.40	2.28	0.46
Macrophage - monocyte derived, donor2	11313-117C8	54.32	75.97	4.95	1.65	9.36	7.16	6.97	2.02	0.37
Macrophage - monocyte derived, donor3	11389-118C3	44.96	112.73	8.52	0.92	14.68	16.39	11.93	1.84	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	130.63	63.72	44.07	3.19	8.50	7.43	1.06	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	147.04	51.50	27.25	5.55	4.91	3.33	1.43	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	135.10	56.85	27.24	4.86	1.95	4.17	0.28	0.14	0.14
Mammary Epithelial Cell, donor1	11273-116H4	157.74	84.70	29.00	3.59	1.99	2.49	1.49	0.00	0.50
Mammary Epithelial Cell, donor2	11350-117G9	112.06	61.67	11.58	5.21	2.61	2.03	1.74	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	32.67	24.69	6.73	0.50	0.50	1.50	0.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	247.45	283.38	84.06	14.91	12.20	35.93	10.85	2.03	0.68
Mast cell, donor1	11563-120D6	68.45	158.53	12.44	9.84	2.92	6.81	8.43	1.30	0.87
Mast cell, donor2	11565-120D8	70.43	229.12	12.78	3.27	4.75	8.92	7.13	2.67	0.30
Mast cell, donor3	11566-120D9	97.70	165.92	12.38	2.48	3.83	3.60	5.18	3.15	0.00
Mast cell, donor4	11567-120E1	73.57	223.38	16.67	1.77	6.03	4.79	8.69	3.90	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	125.64	125.53	17.96	6.54	2.55	4.10	5.32	1.11	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	176.27	221.80	42.03	3.50	8.76	14.59	16.34	4.09	1.17
Mast cell, expanded, donor5	11939-126A4	88.68	117.13	8.26	5.51	1.95	4.02	3.10	0.80	0.92
Mast cell, expanded, donor8	11941-126A6	54.06	158.83	6.19	6.69	5.36	5.36	11.21	2.51	1.34
Melanocyte - dark, donor1	11502-119F8	65.17	127.06	6.67	2.49	3.38	8.06	5.57	0.40	0.50
Melanocyte - dark, donor2	11582-120F7	86.87	55.72	13.50	2.08	0.69	2.42	0.69	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	71.14	26.22	6.95	1.67	0.80	0.87	0.65	0.07	0.07
Melanocyte - light, donor1	11274-116H5	50.78	27.27	4.94	0.24	0.71	1.18	0.94	0.71	0.00
Melanocyte - light, donor2	11351-117H1	32.08	15.01	4.09	1.36	0.00	0.68	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	28.62	22.55	0.87	0.00	0.87	0.87	0.87	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	81.53	32.90	10.20	2.19	0.31	0.73	0.21	0.10	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	76.92	46.80	8.07	2.96	0.27	1.34	0.81	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	65.09	29.46	4.29	1.87	0.00	0.27	0.80	0.27	1.07
Meningeal Cells, donor1	11493-119E8	133.61	63.77	20.72	1.36	0.50	0.37	1.36	0.00	0.00
Meningeal Cells, donor2	11573-120E7	139.97	44.01	22.89	0.88	0.88	0.00	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	151.76	58.52	18.58	2.61	0.65	2.93	1.55	0.00	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	116.63	38.21	10.55	2.57	0.57	0.57	0.57	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	129.01	75.37	27.47	1.01	3.82	2.72	1.41	0.10	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	61.77	110.39	5.26	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	128.20	44.48	19.62	0.00	2.62	2.62	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	205.95	57.41	31.57	2.15	0.72	1.44	1.44	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	116.05	32.82	8.26	2.75	0.85	1.27	0.21	0.64	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	104.55	28.65	14.07	3.02	1.01	1.51	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	172.95	40.21	15.60	2.86	0.66	0.66	0.22	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	129.31	17.53	13.15	2.19	0.73	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	121.53	36.21	18.82	0.00	0.82	1.02	0.41	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	95.43	50.14	9.14	3.32	0.69	0.14	0.69	0.00	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	99.62	45.72	13.38	0.74	1.12	0.37	1.12	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	161.97	77.37	10.66	3.16	0.92	0.92	0.53	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	103.86	89.62	11.57	0.00	1.19	0.30	0.89	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	100.43	105.10	4.67	2.34	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	174.83	46.11	16.01	1.28	1.28	3.20	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	216.92	66.28	32.25	1.06	1.42	1.42	2.84	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	141.04	72.24	14.70	1.56	1.25	0.94	0.63	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	158.93	50.07	20.32	0.00	0.00	3.63	2.18	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	146.11	42.69	31.03	2.39	4.77	3.45	1.06	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	122.11	51.05	41.04	2.00	5.00	3.50	0.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	98.71	42.20	23.92	2.96	2.38	3.47	0.94	0.43	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	27.01	144.48	8.10	1.35	27.01	21.61	8.10	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	46.30	134.47	7.88	1.97	13.05	8.62	9.85	1.72	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	51.53	107.77	9.13	0.88	13.84	10.60	10.31	1.18	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	79.51	3.46	0.00	31.11	10.37	10.37	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	34.71	110.96	8.06	2.48	10.23	8.99	11.47	2.17	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	40.86	85.88	8.71	0.41	8.30	9.54	6.64	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	25.48	78.75	6.95	0.00	16.21	13.90	2.32	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	39.54	134.39	12.51	0.50	11.26	10.01	11.51	1.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	45.15	115.90	9.31	0.93	6.98	9.31	8.38	2.33	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	77.86	0.00	0.00	0.00	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	40.64	131.07	8.33	0.61	10.57	8.74	9.96	1.02	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	53.45	97.01	7.13	0.79	7.13	13.46	7.52	0.79	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	34.21	0.00	0.00	17.10	42.76	0.00	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	35.40	89.38	7.08	0.00	9.73	5.31	9.73	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	47.49	100.68	8.74	0.38	11.40	9.12	12.16	1.90	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	11.84	72.37	6.58	0.00	18.42	17.11	6.58	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	34.38	112.69	8.49	0.42	6.79	9.76	12.10	0.85	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	18.42	60.77	7.37	0.00	12.89	7.37	3.68	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	33.08	97.76	8.64	0.30	9.24	8.94	8.94	2.09	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	11.74	48.62	0.00	0.00	13.41	3.35	3.35	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00	0.00	101.85	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	35.13	106.63	11.29	0.75	8.03	9.79	8.78	3.26	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	39.22	71.06	6.18	1.19	9.27	7.13	7.84	0.95	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	11.61	50.31	4.98	0.00	15.48	6.63	5.53	3.87	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	33.62	79.90	7.14	0.46	7.60	9.90	7.83	0.92	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	33.86	85.82	9.68	0.00	8.41	14.09	7.78	0.63	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	22.42	75.01	7.13	0.20	9.38	11.82	6.32	1.63	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	40.33	89.68	8.37	0.00	8.37	11.37	7.72	0.86	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	29.34	79.80	6.00	0.44	9.34	7.56	7.78	0.89	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00	20.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	23.00	67.46	7.23	0.00	8.10	5.48	4.82	1.75	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	18.25	54.75	7.60	0.00	10.65	7.60	8.11	2.53	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	49.71	0.00	0.00	19.88	11.60	4.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	23.10	64.96	6.25	0.27	8.97	12.23	3.53	1.36	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	33.53	74.70	9.12	0.00	7.06	5.88	7.65	1.76	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	46.88	4.36	0.00	10.90	11.99	7.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	28.35	78.81	9.13	0.48	7.21	12.01	5.29	1.92	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	37.62	80.05	8.81	0.40	7.60	8.00	7.20	1.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	16.45	35.65	1.37	0.00	10.97	6.86	1.37	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	30.54	80.59	12.01	0.50	5.51	10.01	8.51	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	80.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	18.35	4.08	0.00	2.04	6.12	2.04	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	35.91	77.51	8.32	0.00	5.26	9.63	3.07	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	15.45	60.70	5.52	0.00	11.04	4.41	4.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	14.09	32.02	5.12	0.00	7.04	10.25	2.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	33.96	70.66	12.40	0.00	9.92	9.92	3.97	1.74	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	18.79	49.41	7.65	0.70	12.53	6.26	8.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	39.78	2.21	0.00	26.52	2.21	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	24.96	55.73	8.55	0.34	5.13	3.76	6.15	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	21.01	49.89	7.88	0.00	9.63	5.25	5.25	1.31	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.88	39.77	3.20	0.36	8.17	2.49	2.49	1.07	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	30.30	60.60	5.89	0.56	5.61	6.45	3.93	1.68	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	20.78	52.37	9.14	0.42	12.88	5.40	4.16	2.08	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	10.49	43.71	2.91	0.00	3.50	5.24	2.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	25.94	43.74	6.03	0.90	4.52	4.22	6.33	0.90	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	31.30	84.31	11.69	1.25	8.35	7.93	4.17	1.67	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	21.66	0.00	0.00	14.44	0.00	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	16.62	32.32	5.54	0.00	10.16	4.62	8.31	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	29.59	81.95	9.68	0.57	9.11	4.55	4.55	2.85	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	14.79	65.91	5.94	0.14	7.46	8.71	4.42	0.69	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	30.32	71.52	7.52	0.78	3.37	5.44	5.70	2.59	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	24.45	80.65	11.58	0.43	13.73	9.87	5.58	2.14	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	36.21	3.81	0.64	5.08	10.80	4.45	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	18.95	53.11	6.67	0.00	8.27	8.27	2.67	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	41.01	133.80	16.76	0.90	20.65	11.97	11.67	2.10	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	17.94	70.63	7.20	0.42	7.06	9.32	3.53	0.85	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	33.13	79.95	8.92	0.32	7.96	7.96	5.73	1.59	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	39.36	95.75	19.02	0.44	10.17	9.95	6.86	2.43	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.89	47.78	5.69	0.38	5.31	8.72	6.83	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	29.55	82.11	10.80	0.57	7.95	6.82	5.68	1.99	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	46.95	106.43	22.37	0.49	16.71	10.57	10.57	1.97	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	6.52	39.10	1.96	0.65	7.82	10.43	1.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	31.46	79.98	6.76	0.29	7.94	6.47	8.53	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	44.40	135.51	18.45	0.86	27.10	14.99	14.13	2.31	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	28.85	95.62	5.36	1.24	14.43	16.49	16.49	1.65	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	29.48	90.23	7.15	0.30	10.12	14.89	7.74	1.49	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	64.04	143.14	3.77	0.00	22.60	18.83	41.44	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	44.56	172.88	16.04	1.78	24.95	14.26	21.39	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	43.37	152.13	11.50	0.66	22.67	18.07	17.74	3.94	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	69.43	136.75	1.05	0.00	23.14	16.83	17.88	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	50.21	188.99	9.29	2.37	18.58	10.87	21.35	1.38	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	55.88	169.50	6.52	3.73	14.90	14.90	13.97	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	55.95	147.58	4.88	2.25	18.40	9.76	18.40	3.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	43.41	128.64	3.46	0.00	12.52	11.99	10.39	2.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	31.78	116.95	6.33	1.24	15.27	12.89	12.10	1.24	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	43.47	114.93	3.68	0.74	13.26	9.58	11.79	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	44.34	170.75	9.53	0.73	19.42	16.12	16.49	2.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	49.78	127.56	6.22	1.56	12.44	4.67	21.78	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	53.98	177.97	6.95	0.53	32.07	22.98	23.52	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	54.09	177.74	7.73	0.00	7.73	11.59	15.46	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	35.35	143.41	10.10	0.00	21.21	21.21	16.16	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	43.01	135.35	8.43	0.84	27.83	16.44	17.71	1.69	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	21.79	243.79	14.98	1.36	40.86	10.90	29.96	4.09	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	32.43	174.21	8.27	0.64	18.44	12.08	19.71	3.18	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	46.16	175.73	4.86	0.00	31.58	17.01	28.34	4.05	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	40.78	143.49	6.04	1.51	42.29	18.13	25.68	3.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	165.59	0.00	0.00	137.04	11.42	17.13	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	52.20	140.29	9.79	3.26	68.51	29.36	19.57	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	76.04	4.75	0.00	47.52	4.75	9.50	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	75.29	0.00	0.00	125.49	12.55	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	145.42	51.92	23.70	1.94	3.23	3.66	1.08	0.65	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	98.77	45.99	7.32	2.61	2.61	3.66	1.57	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	72.76	22.69	16.02	0.00	0.67	1.33	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	55.93	16.28	12.10	0.00	0.83	1.67	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	72.63	20.92	8.75	1.71	1.33	1.90	0.38	0.19	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	76.60	35.11	12.77	3.19	4.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	46.24	14.28	10.20	0.68	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	38.59	11.03	3.68	0.00	0.00	0.00	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	60.69	19.67	6.70	0.84	2.09	0.42	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	70.66	22.55	14.88	1.39	1.16	1.63	0.70	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	55.13	20.27	10.54	1.08	0.27	0.00	0.54	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	58.03	33.01	6.73	2.73	1.89	1.05	0.84	0.00	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	33.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	72.47	29.29	12.41	0.00	1.49	0.99	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	72.00	28.96	8.93	1.08	1.35	0.81	0.27	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	60.75	25.39	10.43	0.68	0.68	0.91	1.36	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	55.20	20.25	8.00	1.14	0.49	0.33	0.16	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	62.51	28.98	13.49	2.19	0.73	0.91	0.18	0.18	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	56.23	23.34	12.20	1.06	1.06	0.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	60.63	22.21	6.00	0.00	1.80	0.00	1.20	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	46.93	21.99	8.86	3.94	0.66	0.33	0.33	0.98	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	41.96	19.35	7.97	0.81	0.81	0.65	0.81	0.49	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	62.79	31.22	10.41	2.29	1.59	0.53	1.59	0.35	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	54.15	30.24	18.28	0.00	1.41	1.41	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	47.81	28.04	6.90	0.46	0.00	0.46	2.30	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	83.23	30.85	16.71	0.96	0.64	1.29	0.32	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	46.22	27.59	4.83	6.21	1.03	0.69	1.38	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	25.28	22.76	0.00	7.59	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	49.68	31.41	8.47	1.34	0.89	0.67	0.00	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	63.93	26.67	13.55	0.42	0.42	0.85	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	52.22	22.07	8.07	2.37	1.42	0.47	1.19	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	124.48	35.20	24.90	0.43	0.43	1.29	1.29	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	18.06	9.03	54.17	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	63.98	25.99	11.66	1.33	1.33	1.00	1.00	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	68.98	30.66	16.68	2.25	0.45	0.00	0.90	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	63.88	20.24	12.30	0.40	0.79	1.59	0.79	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	76.15	32.50	12.07	0.00	0.00	0.00	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	115.78	35.19	19.68	1.89	1.14	1.51	0.76	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	77.56	30.63	21.18	1.30	0.65	1.63	0.65	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	50.99	18.30	5.23	0.87	0.44	0.87	0.44	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	72.37	35.28	14.93	3.17	2.26	1.36	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	77.61	25.58	14.99	0.00	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	67.15	27.26	9.31	1.33	0.00	0.66	1.33	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	93.26	28.77	15.87	0.99	0.99	0.00	0.50	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	76.57	28.33	17.61	1.15	0.77	1.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	65.63	21.17	5.75	4.84	0.91	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	80.45	31.61	17.24	1.33	0.22	1.11	0.44	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	54.21	27.78	11.52	2.03	1.36	0.00	0.68	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	40.88	5.11	10.22	15.33	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	85.97	23.78	11.58	3.05	1.83	0.61	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	71.76	37.45	17.94	0.31	2.52	1.26	1.26	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	59.62	28.75	6.66	0.91	0.30	0.61	0.30	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	91.77	26.11	18.99	0.79	0.00	0.00	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	37.41	30.61	6.80	6.80	0.00	1.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	50.58	20.23	0.00	10.12	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	123.86	43.48	35.16	2.11	3.23	3.85	1.86	0.25	0.12
Myoblast, donor2	11322-117D8	107.59	36.25	14.38	2.88	0.77	1.73	2.30	0.38	0.00
Myoblast, donor3	11398-118D3	111.32	33.63	15.98	2.52	3.87	1.35	1.01	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	132.51	99.96	13.28	11.53	2.77	3.21	2.92	0.44	1.46
Natural Killer Cells, donor1	11230-116C6	123.01	176.82	29.21	2.46	7.38	6.15	4.00	1.23	0.00
Natural Killer Cells, donor2	11311-117C6	89.56	128.46	20.51	5.73	3.32	2.41	1.21	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	85.03	134.54	19.33	2.21	4.97	4.05	3.31	0.55	0.37
Neural stem cells, donor1	11275-116H6	104.53	27.58	11.98	16.33	0.73	0.73	1.09	0.36	1.81
Neural stem cells, donor2	11352-117H2	90.51	26.96	15.41	17.33	1.93	3.85	0.00	0.00	0.00
Neurons, donor1	11494-119E9	91.03	22.76	19.34	4.55	2.28	3.41	1.14	0.00	1.14
Neurons, donor2	11574-120E8	73.31	20.26	9.03	7.71	0.66	1.32	0.22	0.00	0.22
Neurons, donor3	11655-122E8	84.68	20.55	18.09	5.76	4.93	4.11	0.82	0.00	1.64
Neutrophils, donor1	11233-116C9	32.48	243.14	8.35	0.00	74.24	40.83	38.05	8.35	0.00
Neutrophils, donor2	11314-117C9	26.09	127.55	8.70	0.00	34.79	43.48	34.79	2.90	0.00
Neutrophils, donor3	11390-118C4	51.31	259.61	17.71	0.61	130.72	45.20	72.08	12.83	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	93.33	43.34	5.46	8.55	0.24	0.71	0.59	0.12	0.83
Nucleus Pulposus Cell, donor2	11409-118E5	68.05	36.79	5.86	5.86	0.65	0.00	2.28	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	78.42	28.28	6.22	1.80	0.60	0.00	0.40	0.00	0.40
Olfactory epithelial cells, donor1	11933-125I7	92.09	48.32	13.63	1.10	2.20	1.24	1.24	0.00	0.14
Olfactory epithelial cells, donor2	11934-125I8	121.73	46.90	20.12	2.03	1.16	2.32	1.16	0.29	0.14
Olfactory epithelial cells, donor3	11935-125I9	111.58	55.50	16.34	1.82	1.36	1.48	1.70	0.45	0.23
Olfactory epithelial cells, donor4	11936-126A1	142.30	68.96	23.76	1.27	1.66	2.53	1.17	0.19	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	149.25	52.96	22.27	3.01	1.20	2.41	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	88.06	60.83	13.83	1.06	0.64	0.64	1.28	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	54.87	30.86	5.72	1.14	0.00	2.29	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	76.35	63.93	10.55	0.62	0.62	1.24	1.24	0.62	0.00
Osteoblast, donor1	11277-116H8	84.04	47.49	11.14	0.78	1.37	2.35	0.59	0.00	0.00
Osteoblast, donor2	11354-117H4	174.88	47.06	16.86	2.11	2.11	1.40	2.11	0.00	0.00
Osteoblast, donor3	11426-118G4	129.57	47.45	26.13	0.53	1.24	2.13	0.89	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	135.96	47.17	14.74	3.54	1.18	1.60	0.34	0.17	0.25
Pericytes, donor1	11491-119E6	64.76	28.82	4.23	1.67	0.22	0.45	0.33	0.11	0.00
Pericytes, donor2	11571-120E5	67.23	31.92	8.15	1.58	1.36	0.68	0.68	0.00	0.00
Pericytes, donor3	11652-122E5	169.88	63.27	30.11	0.41	1.83	2.64	1.02	0.41	0.00
Perineurial Cells, donor1	11499-119F5	177.56	65.33	17.63	2.26	0.57	1.36	1.02	0.11	0.11
Perineurial Cells, donor2	11579-120F4	108.30	65.79	15.00	2.21	0.46	1.20	1.10	0.09	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	80.96	251.49	9.56	3.19	14.66	10.52	24.54	4.14	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	47.01	188.05	11.75	1.71	17.39	10.28	25.71	2.45	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	54.23	184.29	13.72	2.07	19.54	13.72	21.22	3.36	0.26
Placental Epithelial Cells, donor1	11278-116H9	90.40	24.87	15.78	0.24	2.63	0.96	0.72	0.24	0.48
Placental Epithelial Cells, donor2	11355-117H5	125.30	24.40	6.65	3.33	3.33	0.00	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	60.08	32.20	7.85	0.59	0.79	0.39	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	140.50	60.13	33.23	0.63	1.90	4.43	1.27	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	142.57	41.08	15.94	1.31	2.06	1.88	2.25	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	84.97	18.93	17.36	1.04	0.52	1.57	0.39	0.13	0.26
Preadipocyte - breast, donor2	11328-117E5	152.88	53.14	29.27	0.45	3.15	2.25	2.03	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	121.90	30.90	17.69	1.49	2.24	1.28	0.75	0.43	0.00
Preadipocyte - omental, donor2	11329-117E6	128.76	41.46	23.57	1.75	1.75	6.11	1.31	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	157.00	57.59	30.94	1.58	4.44	5.16	2.15	2.01	0.14
Preadipocyte - perirenal, donor1	11469-119C2	81.69	54.13	23.62	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	177.82	54.67	44.53	0.61	0.61	3.69	0.92	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	250.39	58.61	36.48	1.95	1.24	3.36	2.30	0.53	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	219.50	60.79	41.04	1.36	2.89	4.77	1.36	1.36	0.00
Preadipocyte - visceral, donor1	11280-116I2	186.48	57.10	29.16	3.91	2.33	1.77	1.21	0.93	0.37
Preadipocyte - visceral, donor2	11357-117H7	173.95	52.92	27.61	3.68	2.30	5.52	1.38	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	131.55	39.81	27.06	0.84	1.04	0.84	0.52	0.31	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	155.98	79.65	32.43	9.96	4.53	3.32	1.81	2.56	0.91
Prostate Epithelial Cells, donor2	11331-117E8	91.54	33.99	27.08	4.60	3.11	2.84	1.35	4.20	0.95
Prostate Epithelial Cells, donor3	11404-118D9	147.83	62.52	19.72	5.88	1.04	0.92	0.80	2.14	0.24
Prostate Stromal Cells, donor1	11254-116F3	184.29	49.32	26.88	3.30	2.73	1.59	0.80	0.23	0.68
Prostate Stromal Cells, donor2	11332-117E9	229.86	65.26	45.90	2.69	1.08	3.41	0.90	0.36	0.36
Prostate Stromal Cells, donor3	11405-118E1	109.39	49.64	14.18	1.88	0.94	1.77	0.52	0.21	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	83.95	63.87	12.04	1.09	0.36	0.73	1.09	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	96.20	43.87	8.46	3.95	0.90	0.35	1.32	0.00	0.49
Renal Epithelial Cells, donor1	11517-119H5	99.42	45.14	11.16	1.01	0.51	0.00	1.52	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	54.77	29.16	5.69	1.42	2.13	0.00	2.13	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	103.75	33.35	8.05	3.07	1.06	0.42	0.53	0.00	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	40.17	53.11	2.72	0.00	0.68	0.68	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	61.45	51.61	11.05	1.35	0.81	1.35	1.75	0.81	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	103.01	61.72	13.99	1.78	1.55	5.11	2.66	0.00	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	61.22	96.49	5.99	1.33	4.66	3.99	2.66	2.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	104.32	33.89	9.46	1.54	1.10	0.88	0.66	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	85.90	35.11	6.90	0.63	0.00	0.63	1.25	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	58.81	30.24	6.66	0.28	0.55	0.55	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	147.90	64.96	17.72	0.27	1.34	2.42	1.34	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	96.99	53.13	19.40	0.84	1.27	2.11	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	76.37	39.73	7.91	1.74	0.77	0.58	1.54	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	86.34	28.26	6.22	2.07	0.26	0.52	0.26	0.26	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	58.55	26.15	5.68	1.71	0.28	0.57	0.85	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	73.07	21.61	5.15	1.03	1.03	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	69.25	24.84	3.26	3.76	0.75	0.00	0.50	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	182.28	124.15	34.21	10.69	6.95	7.22	5.21	2.00	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	83.98	65.22	16.08	30.38	0.00	0.89	0.89	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	163.46	73.75	20.91	68.25	0.00	1.65	0.55	0.55	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	113.11	56.27	11.02	55.69	1.16	0.58	1.16	0.00	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	93.88	43.82	26.66	18.07	1.04	0.91	0.39	0.26	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	112.81	49.26	25.92	11.82	1.89	2.28	1.39	0.00	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	140.87	59.23	26.10	20.19	2.12	2.68	1.34	0.22	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	108.79	51.85	30.76	15.13	1.49	1.36	0.74	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	124.59	57.34	30.42	10.61	1.17	1.86	0.82	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	129.43	46.00	28.89	23.34	1.39	2.54	1.39	0.00	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	94.19	39.70	31.76	13.96	0.68	0.96	0.00	0.00	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	98.93	43.11	25.41	12.86	0.91	1.66	1.36	0.00	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	135.29	62.00	30.82	13.98	1.25	3.23	0.54	0.00	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	103.29	48.49	32.71	15.06	1.00	0.43	1.15	0.43	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	111.82	48.40	26.51	9.87	0.64	2.58	0.97	0.32	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	118.38	55.32	28.54	19.25	1.55	3.32	0.89	0.00	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	82.40	36.32	29.63	11.28	0.76	0.57	1.15	0.00	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	104.72	48.91	23.48	10.90	1.02	2.70	1.12	0.28	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	157.28	61.07	28.75	19.54	2.07	3.38	0.75	0.19	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	90.90	43.93	27.34	11.55	0.53	0.53	0.40	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	101.33	44.29	23.07	11.19	1.36	2.53	0.29	0.29	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	133.10	51.56	29.03	18.14	1.53	2.67	1.53	0.00	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	97.18	43.36	27.34	14.52	0.96	0.43	0.96	0.21	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	96.99	41.20	17.66	8.69	1.68	1.96	1.12	0.00	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	128.34	46.31	26.15	16.75	0.68	3.08	0.51	0.34	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	88.98	43.03	30.27	12.76	1.09	1.28	1.09	0.18	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	108.65	45.86	22.32	9.44	0.86	2.33	1.10	0.37	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	118.07	50.50	25.52	14.91	0.94	2.28	0.40	0.00	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	123.83	43.87	41.28	19.34	1.65	0.71	0.71	0.00	2.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	112.30	54.56	23.02	8.53	1.59	1.39	1.19	0.00	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	124.17	46.07	25.96	16.84	1.40	2.57	1.40	0.00	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	130.84	52.05	36.70	12.65	0.83	0.21	0.41	0.00	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	109.50	34.51	15.71	16.81	1.77	1.55	0.88	0.22	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	115.30	48.04	29.66	12.74	1.67	2.09	1.25	0.00	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	122.74	44.55	34.86	14.80	0.81	0.81	1.21	0.13	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	93.66	43.25	18.05	9.03	1.53	2.21	1.02	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	127.63	51.48	26.22	16.00	1.35	4.24	0.77	0.00	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	110.21	40.23	31.98	15.99	1.03	0.52	1.03	0.17	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	99.31	39.64	19.89	10.97	1.10	2.47	1.37	0.14	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	97.02	50.89	27.25	18.72	0.99	2.79	0.66	0.33	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	86.41	38.35	28.80	17.21	0.51	0.85	0.51	0.17	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	89.81	43.65	20.42	12.13	1.04	1.92	0.89	0.15	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	93.83	55.98	23.99	16.53	0.53	4.26	1.07	0.00	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	89.87	48.25	18.39	18.25	0.69	0.28	0.14	0.14	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	106.43	50.72	19.29	14.52	0.00	2.86	1.67	0.24	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	114.68	57.84	23.18	20.15	0.00	2.82	0.81	0.20	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	87.39	59.33	21.28	22.70	0.19	0.47	1.04	0.28	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	112.49	52.75	17.82	28.30	0.70	1.75	1.05	0.35	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	88.25	64.07	21.46	27.20	1.21	3.32	0.91	0.30	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	108.43	67.19	29.74	17.87	1.22	0.98	0.86	0.37	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	136.96	80.34	20.38	84.86	1.31	2.18	1.60	0.15	5.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	123.51	62.67	17.04	40.16	1.83	1.83	1.83	1.22	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	110.01	60.88	33.76	19.59	0.60	1.51	0.60	0.30	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	119.20	64.92	17.64	22.85	1.13	3.17	1.58	0.23	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	128.50	70.09	26.06	35.65	0.60	3.00	1.20	0.30	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	101.66	59.16	25.50	24.91	0.71	0.59	0.71	0.59	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	124.87	89.86	26.89	21.56	1.07	3.20	1.28	0.00	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	120.20	51.08	25.84	27.64	0.00	6.01	1.80	0.60	2.40
Schwann Cells, donor1	11498-119F4	97.42	40.62	13.35	1.13	0.75	0.19	1.32	0.00	0.19
Schwann Cells, donor2	11578-120F3	98.67	51.04	6.80	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	126.41	36.81	12.05	0.88	0.88	1.10	0.88	0.00	0.00
Sebocyte, donor1	11220-116B5	113.94	47.66	20.82	1.10	1.64	0.00	0.00	0.00	0.55
Sebocyte, donor2	11301-117B5	89.61	38.14	20.68	1.84	1.38	1.38	0.92	0.00	0.00
Sebocyte, donor3	11378-118B1	93.16	49.67	16.90	1.03	0.82	1.24	0.62	0.21	0.00
Sertoli Cells, donor1	11255-116F4	130.87	64.61	16.57	0.00	1.66	3.31	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	101.68	11.30	8.47	2.82	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	86.66	48.92	6.51	3.61	1.41	0.35	1.06	0.26	0.26
Skeletal Muscle Cells, donor2	11358-117H8	48.43	30.36	7.95	0.00	0.00	0.72	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	79.42	15.88	13.38	0.00	0.00	0.00	0.00	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	141.23	40.37	25.76	3.93	0.94	0.16	0.94	0.00	0.31
Skeletal Muscle Cells, donor5	11455-119A6	130.21	39.09	22.59	3.42	0.45	0.30	0.74	0.30	0.30
Skeletal Muscle Cells, donor6	11459-119B1	170.83	43.25	22.16	2.31	1.23	0.31	0.62	0.15	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	150.58	64.77	12.35	9.07	0.50	0.88	0.76	0.00	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	144.40	49.51	11.13	6.85	1.71	0.57	1.43	0.29	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	169.65	52.78	23.12	1.98	1.49	1.98	0.79	0.10	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	106.92	42.21	15.00	2.19	0.59	0.59	0.67	0.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	49.94	25.33	3.62	0.00	0.72	0.72	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	60.82	19.40	8.67	0.69	1.10	0.69	1.10	0.41	0.00
Skin - palm, donor1	10286-104F7	56.41	32.23	2.69	2.69	0.00	2.69	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	81.45	47.72	25.23	1.44	2.59	2.59	1.01	0.72	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	60.52	22.90	17.99	28.63	0.82	0.00	1.64	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	89.58	54.53	20.38	1.17	0.91	1.82	1.69	0.52	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	196.00	80.76	36.42	6.12	2.78	4.87	2.36	2.50	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	113.79	64.84	33.76	3.38	2.95	4.78	1.55	0.56	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	77.81	31.51	24.10	13.96	0.85	1.69	0.21	0.00	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	229.35	80.80	47.67	1.72	2.92	3.45	1.57	2.25	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	185.46	59.56	51.22	2.78	0.93	1.23	1.54	1.85	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	82.71	26.46	19.79	2.00	1.11	0.00	0.67	0.89	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	161.06	59.37	37.03	2.35	2.94	4.70	0.59	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	94.14	60.77	27.40	1.33	1.55	5.30	1.10	1.33	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	104.75	62.61	43.71	1.18	2.76	4.33	1.97	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	167.65	79.57	34.77	1.55	4.64	1.55	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	86.07	28.02	6.00	6.00	0.00	0.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	136.67	67.07	42.98	0.93	3.73	4.52	1.73	0.40	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	170.01	53.86	29.48	2.44	2.88	2.88	1.11	1.11	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	117.92	79.76	54.67	4.23	10.11	4.23	3.97	0.38	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	126.98	44.28	14.65	2.93	0.65	0.98	1.30	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	137.62	37.21	15.65	1.77	1.18	1.48	0.59	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	120.87	51.68	21.21	1.42	1.14	1.14	1.14	0.28	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	164.30	36.11	13.66	1.46	1.63	0.98	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	84.63	34.71	8.52	4.26	1.22	0.30	0.61	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	85.11	38.89	10.10	2.02	0.51	0.51	1.52	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	91.81	24.48	18.36	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	107.29	61.51	41.96	3.34	2.38	1.43	1.43	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	152.93	37.90	19.61	3.69	0.74	0.44	0.15	0.00	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	149.16	44.77	18.73	1.94	0.86	0.86	1.08	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	166.25	51.43	26.55	3.04	0.63	1.26	0.42	0.10	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	121.42	74.09	44.70	1.08	4.49	7.89	2.63	0.93	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	106.71	68.98	30.18	3.23	5.39	8.62	5.39	3.23	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	104.60	56.18	42.14	1.79	3.89	2.69	1.49	0.90	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	159.77	51.21	22.19	1.02	1.02	0.68	0.68	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	115.28	62.59	7.62	7.30	0.55	0.55	0.63	0.08	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	131.74	42.57	30.90	8.35	3.82	3.42	2.21	6.94	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	124.93	65.31	48.70	6.14	4.78	7.28	1.59	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	102.65	62.80	34.42	2.42	3.02	2.42	1.81	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	176.97	58.81	28.08	4.50	0.53	2.12	0.53	0.26	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	141.15	43.14	20.91	3.06	1.86	0.93	0.40	0.53	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	150.51	48.71	18.03	3.01	2.13	1.13	0.88	1.13	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	84.22	43.38	7.36	0.25	2.03	0.51	0.00	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	149.87	67.09	31.21	4.98	1.66	5.13	2.26	0.60	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	71.27	42.01	14.25	1.50	0.00	1.50	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	59.44	72.36	9.05	0.00	1.29	1.29	1.29	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	156.73	65.11	27.90	0.00	1.40	0.93	0.93	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	120.67	92.39	58.06	4.54	6.06	10.60	2.52	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	85.56	55.78	55.78	2.51	5.95	4.70	3.45	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	86.14	26.55	6.78	0.59	0.88	0.29	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	128.46	43.57	15.91	3.33	1.17	1.33	0.58	0.08	0.67
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	86.42	40.18	5.61	3.74	1.40	0.47	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	131.97	110.24	75.99	1.30	7.48	11.95	4.03	0.86	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	140.23	81.59	48.44	2.55	5.10	9.69	4.84	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	86.31	53.59	27.26	0.56	1.69	1.13	1.13	0.56	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	146.87	48.07	14.67	1.96	1.40	1.26	0.84	0.14	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	167.07	71.97	16.67	0.84	1.34	1.68	0.92	0.08	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	160.47	79.52	19.52	0.95	1.90	0.95	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	108.39	98.60	58.96	1.71	9.30	12.23	3.43	1.22	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	176.76	72.47	66.73	2.43	4.86	2.21	1.10	1.33	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	114.98	36.86	18.43	2.93	1.17	1.46	1.17	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	105.93	36.54	9.33	2.92	0.78	0.97	0.97	0.78	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	101.55	30.15	15.34	1.85	1.85	0.79	0.26	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	155.85	26.41	23.80	2.98	1.12	1.12	0.37	1.12	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	132.95	42.76	34.86	3.59	4.31	1.80	0.00	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	94.54	26.12	24.42	1.70	3.12	2.56	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	117.77	38.99	20.88	0.39	1.18	1.97	0.79	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	96.50	37.33	11.94	5.08	0.76	0.76	0.76	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	106.22	36.74	9.18	4.79	0.00	0.00	1.20	1.20	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	99.07	45.98	9.20	2.09	1.25	0.84	0.84	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	101.30	43.09	6.42	3.67	0.00	0.00	0.92	0.00	0.46
Synoviocyte, donor1	11291-117A4	195.42	64.30	41.07	1.51	2.36	2.69	1.18	0.67	0.17
Synoviocyte, donor2	11368-117I9	89.68	51.46	11.73	3.02	1.34	1.68	1.17	0.00	0.17
Synoviocyte, donor3	11440-118H9	76.63	41.78	6.26	3.57	1.34	0.45	0.67	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	142.22	46.81	15.01	2.14	1.43	1.43	1.43	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	110.99	67.39	1.98	1.98	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	96.32	46.08	11.58	2.08	0.46	0.00	0.00	0.23	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	119.00	65.52	17.71	1.72	1.00	1.00	1.15	0.29	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	51.80	31.70	11.98	0.77	0.77	1.93	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	51.54	38.37	17.18	1.15	1.15	1.72	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	182.32	115.77	34.08	9.96	7.50	8.37	4.80	0.98	1.23
Urethra, donor2	10319-105A4	89.92	66.54	8.99	10.79	1.80	0.00	1.80	1.80	1.80
Urothelial Cells, donor1	11520-119H8	110.78	53.66	15.41	0.80	1.86	1.59	0.80	0.27	0.00
Urothelial Cells, donor2	11600-120H7	64.09	53.68	8.41	1.60	1.60	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	76.78	57.76	13.52	1.60	0.23	0.92	0.69	0.00	0.23
Urothelial cells, donor0	11216-116B1	162.71	90.72	22.07	3.79	1.56	1.78	0.45	0.00	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	88.09	185.07	13.35	3.56	17.80	9.79	12.46	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	94.35	182.99	8.58	4.29	21.44	4.29	15.73	4.29	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	60.92	146.49	12.32	4.79	10.27	15.74	9.58	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	80.92	181.81	7.58	8.61	15.15	8.61	18.59	2.75	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	86.57	194.64	8.13	4.65	21.50	6.97	19.75	1.16	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	63.52	160.35	7.29	2.08	21.87	5.21	16.66	5.21	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	90.86	180.81	16.52	7.34	14.68	3.67	12.85	6.42	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	57.51	125.98	9.13	3.65	11.87	10.95	7.30	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	82.04	27.76	9.87	3.70	0.49	1.11	1.48	0.37	0.12
Wilms' tumor cell line:HFWT	10597-108E3	51.04	19.36	6.16	5.28	0.00	0.00	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	144.69	77.65	24.58	1.12	1.96	2.23	1.68	0.00	0.28
achilles tendon, donor2	10292-104G4	37.20	74.40	10.33	0.00	8.27	6.20	12.40	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	105.04	213.40	27.28	20.14	12.49	19.63	11.98	1.78	2.55
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	76.15	246.80	19.73	5.80	2.09	11.84	6.73	0.70	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	165.48	195.75	27.54	14.24	1.54	3.21	1.54	0.36	1.78
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	198.92	160.00	49.25	6.26	1.36	12.52	1.90	0.54	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	77.86	115.53	19.39	7.03	5.06	15.46	7.31	1.97	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	65.56	205.98	11.00	4.65	7.40	15.44	18.61	0.85	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	87.38	317.13	13.61	8.71	6.26	22.87	13.34	2.18	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	46.71	294.79	14.10	2.20	7.05	18.95	11.90	1.76	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	79.63	384.27	24.09	17.97	9.80	34.71	18.38	4.49	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	57.08	234.53	16.31	4.66	5.05	7.77	8.15	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	36.06	170.38	6.99	2.76	8.10	16.93	13.06	1.29	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	230.13	7.80	3.90	0.00	15.60	3.90	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	64.14	140.13	10.92	5.58	4.18	15.80	4.18	1.39	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	46.86	205.05	13.72	3.62	3.62	7.25	5.18	0.78	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	45.01	241.69	11.11	2.34	7.31	15.20	9.94	0.88	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	39.04	197.06	9.30	4.18	13.01	13.94	14.41	2.79	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	40.30	155.04	7.40	2.88	5.35	11.52	11.10	1.65	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	33.15	157.47	14.43	1.23	5.53	15.65	6.75	3.99	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	40.11	181.35	17.50	4.69	5.12	24.32	7.68	1.28	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	45.80	188.04	14.56	4.85	4.55	22.14	9.71	2.43	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	47.18	200.51	18.53	3.37	9.15	25.03	9.63	1.68	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	60.14	179.53	14.70	3.56	3.56	16.71	7.80	2.67	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	103.40	35.69	16.34	9.67	1.33	0.67	2.00	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	94.77	79.90	20.44	1.86	1.86	9.29	1.86	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	116.01	175.15	19.21	6.78	1.13	11.30	2.26	0.38	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	74.58	115.58	12.21	6.11	4.36	5.23	5.67	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	46.86	133.09	11.25	9.37	3.75	16.87	7.50	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	139.18	102.68	21.43	6.12	1.18	4.47	1.41	0.47	0.94
adipose tissue, adult, pool1	10010-101C1	73.22	66.70	6.05	4.50	4.34	5.58	5.12	0.78	0.16
adipose, donor1	10184-103D4	86.20	62.16	8.80	41.05	1.17	2.93	2.35	0.00	5.86
adipose, donor2	10185-103D5	77.86	30.82	6.49	4.87	1.22	0.41	2.43	0.41	0.41
adipose, donor3	10186-103D6	80.33	33.76	13.61	8.44	1.36	0.82	4.08	0.00	0.54
adipose, donor4	10187-103D7	132.61	50.27	17.34	8.67	0.00	6.93	0.87	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	65.97	9.78	3.47	6.15	0.63	0.32	0.16	0.00	0.47
adrenal gland, adult, pool1	10081-102A9	127.32	61.84	25.46	7.28	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	89.65	134.21	13.61	5.20	1.73	2.40	3.07	0.67	0.93
alveolar cell carcinoma cell line:SW 1573	10708-109H6	100.04	35.73	12.86	1.07	1.07	0.71	1.07	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	168.55	57.96	32.00	3.94	4.87	2.55	0.70	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	180.55	63.90	18.26	11.50	1.35	1.69	1.35	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	113.42	68.35	18.56	10.31	2.36	1.18	0.00	0.29	0.88
amygdala - adult, donor10196	10167-103B5	90.12	27.27	27.27	16.60	9.49	5.93	4.74	0.00	3.56
amygdala, adult, donor10252	10151-102I7	120.24	39.13	21.29	17.44	3.85	5.07	1.82	0.00	3.24
amygdala, newborn, donor10223	10360-105E9	79.08	44.22	38.73	6.78	6.78	6.46	0.97	0.32	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	144.65	182.46	24.32	3.31	6.11	5.48	2.16	0.25	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	123.11	124.65	27.80	3.75	1.54	4.19	2.21	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	40.42	37.08	14.36	12.69	7.01	1.34	1.67	0.33	1.00
aorta, adult, pool1	10052-101G7	105.32	62.37	15.49	2.75	4.51	5.10	3.53	0.20	0.20
appendix, adult	10189-103D9	80.34	117.21	17.85	14.75	6.99	8.15	3.88	0.39	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	91.14	78.76	12.04	5.50	3.44	2.41	1.03	0.00	0.34
artery, adult	10190-103E1	36.68	21.74	2.72	10.87	2.72	0.00	4.08	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	103.00	32.16	7.39	13.47	1.30	1.01	0.87	0.00	1.01
b cell line:RPMI1788	10427-106D4	445.66	624.40	85.95	32.86	11.15	19.18	8.62	1.34	4.01
basal cell carcinoma cell line:TE 354.T	10702-109G9	140.39	43.56	28.58	0.83	1.39	5.27	0.28	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	105.09	109.55	19.05	5.06	3.27	3.57	2.08	0.30	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	236.00	74.15	29.29	2.51	1.84	1.17	0.84	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	23.49	162.74	7.27	5.03	6.71	7.27	11.74	1.12	0.00
bladder, adult, pool1	10011-101C2	115.49	102.01	14.88	9.34	1.20	1.52	4.02	0.11	0.76
blood, adult, pool1	10053-101G8	77.51	135.09	4.43	4.43	11.07	6.64	26.58	6.64	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	64.23	37.68	13.70	1.71	1.71	3.43	0.00	0.00	0.00
bone marrow, adult	10192-103E3	89.08	61.41	8.77	6.75	2.70	2.70	2.02	0.00	0.67
brain, adult, donor1	10084-102B3	72.78	23.58	14.35	4.10	1.03	0.00	2.05	0.00	0.00
brain, adult, pool1	10012-101C3	80.18	32.52	12.36	11.47	4.34	3.45	3.01	0.56	1.11
brain, fetal, pool1	10085-102B4	66.78	50.76	21.37	13.36	0.00	2.67	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	144.04	86.89	22.13	10.24	3.30	3.30	2.64	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	234.04	70.77	46.56	4.37	3.00	3.37	1.00	0.00	0.62
breast, adult, donor1	10080-102A8	109.22	102.91	22.10	0.63	3.16	4.42	2.53	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	120.18	27.44	7.24	4.57	0.51	0.64	1.14	0.13	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	80.71	28.14	8.35	7.11	0.62	0.62	0.31	0.00	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	279.26	47.66	14.50	13.81	1.38	1.15	0.69	0.00	2.30
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	129.52	56.41	15.01	6.78	2.91	0.97	2.18	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	118.48	24.45	8.46	2.82	0.00	0.47	0.94	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	179.93	77.66	38.83	5.14	1.64	2.84	0.77	0.22	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	159.40	83.98	21.55	6.02	0.32	1.27	2.54	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	80.65	33.80	8.78	10.38	0.27	0.00	1.60	0.00	1.60
caudate nucleus - adult, donor10196	10177-103C6	103.62	35.69	11.51	21.88	10.36	2.30	6.91	0.00	3.45
caudate nucleus, adult, donor10252	10164-103B2	130.85	35.98	27.94	21.92	2.34	6.19	2.51	0.33	1.84
caudate nucleus, adult, donor10258	10379-105H1	101.63	48.14	22.16	11.46	3.06	2.29	3.06	0.76	1.53
caudate nucleus, newborn, donor10223	10354-105E3	79.11	48.71	56.40	15.75	10.99	6.96	0.73	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	134.01	43.70	29.13	20.39	0.00	2.91	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	105.90	18.15	19.43	23.27	3.20	2.78	1.49	0.00	1.07
cerebellum, adult, pool1	10083-102B2	63.12	23.46	14.14	7.93	2.41	1.38	2.76	0.34	1.03
cerebellum, newborn, donor10223	10357-105E6	98.80	47.33	30.72	44.01	4.98	3.32	0.83	0.83	0.83
cerebral meninges, adult	10188-103D8	88.75	43.12	34.29	13.87	8.32	6.56	2.77	1.26	1.01
cerebrospinal fluid, donor2	10294-104G6	38.01	27.77	4.39	5.12	5.12	4.39	3.65	1.46	1.46
cervical cancer cell line:D98-AH2	10552-107I3	243.57	195.69	35.80	13.80	4.60	4.74	7.19	0.43	0.72
cervical cancer cell line:ME-180	10553-107I4	239.96	137.05	72.42	15.74	4.97	5.30	0.99	0.33	0.66
cervix, adult, pool1	10013-101C4	146.04	84.94	20.16	7.77	2.52	4.41	3.04	0.52	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	143.94	26.47	16.16	6.97	1.53	1.81	0.84	0.28	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	66.62	52.25	6.53	1.31	1.31	3.92	0.00	1.31	1.31
choriocarcinoma cell line:BeWo	10423-106C9	190.39	96.31	22.37	10.69	1.74	1.99	2.86	1.24	1.99
choriocarcinoma cell line:SCH	10785-110H2	225.60	71.71	35.36	50.76	1.60	3.70	0.86	0.49	6.04
choriocarcinoma cell line:T3M-3	10618-108G6	111.00	65.70	11.62	10.67	0.71	1.19	1.90	0.47	1.66
chorionic membrane cells, donor1	12238-129G6	202.29	54.99	35.61	2.56	3.99	2.85	0.28	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	178.78	43.75	23.86	2.09	1.09	1.69	0.50	0.70	0.10
chorionic membrane cells, donor3	12240-129G8	163.75	68.69	24.73	9.89	1.65	1.65	1.10	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	78.76	145.41	18.18	9.09	5.05	3.03	4.04	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	77.22	170.20	13.64	4.61	9.41	24.97	11.91	2.50	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	53.43	155.01	10.98	1.69	7.18	15.42	7.60	1.27	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	195.94	68.31	24.40	11.56	1.03	1.54	1.03	0.00	2.05
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	204.63	74.50	30.48	14.51	1.45	1.94	0.73	0.00	2.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	190.78	74.11	28.10	19.34	1.22	2.24	2.04	0.00	2.65
chronic myelogenous leukemia cell line:K562	10454-106G4	135.74	41.52	20.91	5.01	1.77	1.47	0.59	0.00	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	110.24	170.45	23.72	3.65	3.39	10.95	1.56	0.78	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	144.69	40.46	13.49	1.37	2.06	2.06	0.69	0.00	0.46
clear cell carcinoma cell line:TEN	10636-108I6	149.56	73.74	30.71	6.42	3.64	3.47	1.21	0.35	0.87
colon carcinoma cell line:CACO-2	10513-107D9	151.01	80.54	32.95	7.50	5.13	2.38	2.93	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	514.25	150.89	45.61	25.47	0.38	1.90	2.66	0.38	3.42
colon, adult, donor1	10082-102B1	71.40	88.06	17.85	1.19	1.19	1.19	3.57	0.00	0.00
colon, adult, pool1	10014-101C5	92.95	110.92	12.34	8.34	5.52	5.99	5.88	0.47	0.35
colon, fetal, donor1	10070-101I7	65.51	108.15	9.27	4.33	2.47	2.47	4.33	1.24	1.85
common myeloid progenitor CMP, donor1	12130-128D6	32.08	297.93	4.58	4.58	22.92	55.00	45.84	4.58	4.58
common myeloid progenitor CMP, donor2	12134-128E1	50.07	525.77	0.00	0.00	50.07	25.04	75.11	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	173.37	148.30	60.77	8.50	2.55	14.02	3.40	0.85	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	143.84	155.61	45.28	7.40	3.77	7.85	4.83	0.91	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	140.17	166.11	41.88	7.33	1.27	9.45	5.08	0.42	0.99
corpus callosum, adult, pool1	10042-101F6	103.38	45.77	13.38	13.49	4.31	1.88	5.09	0.11	1.00
cruciate ligament, donor2	10295-104G7	64.03	45.39	6.48	4.86	8.92	5.67	8.92	1.62	0.81
diaphragm, fetal, donor1	10069-101I6	68.22	32.91	10.43	7.22	2.41	1.61	0.80	0.00	0.00
diencephalon, adult	10193-103E4	69.60	22.56	9.60	13.92	3.12	0.72	2.16	0.00	2.88
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	67.28	176.11	9.18	7.81	1.61	5.28	9.64	0.46	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	163.61	76.16	16.67	9.23	3.85	2.82	2.56	0.00	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	125.18	49.35	14.92	13.00	1.20	0.96	1.69	0.00	0.72
ductus deferens, adult	10196-103E7	220.27	176.41	82.72	24.92	15.95	14.45	9.47	1.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	123.86	109.46	38.89	7.20	10.08	1.44	4.32	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	151.54	107.40	20.60	11.77	3.68	3.68	3.68	0.74	1.47
dura mater, adult, donor1	10041-101F5	84.90	90.68	8.26	3.63	6.52	5.95	9.41	0.50	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	87.05	45.52	23.10	6.88	11.99	7.99	3.11	1.78	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	95.58	27.23	12.18	5.59	1.58	2.15	0.72	0.00	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	90.03	39.46	4.93	5.55	1.23	0.62	0.62	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	94.75	33.60	1.82	5.45	1.21	0.61	0.61	0.00	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	92.01	36.74	8.34	3.09	1.23	1.23	0.31	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	103.76	63.05	5.25	1.31	0.00	0.00	6.57	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	221.23	106.26	48.60	6.37	4.02	5.03	3.35	1.68	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	147.16	91.52	17.76	3.62	1.81	3.08	3.26	0.72	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	123.18	34.09	26.53	2.57	2.41	1.13	0.80	0.32	0.16
epidermoid carcinoma cell line:A431	10426-106D3	205.64	162.63	38.35	6.78	4.78	4.89	2.67	0.78	1.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	78.64	72.15	20.46	7.26	3.96	4.51	1.87	0.44	0.55
epididymis, adult	10197-103E8	194.87	98.59	54.42	20.30	5.23	5.86	2.30	0.84	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	108.57	20.58	9.05	7.45	0.71	0.35	0.35	0.00	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	202.52	93.20	62.92	0.39	0.79	3.93	0.79	1.57	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	103.79	80.20	29.09	7.34	2.49	7.34	3.28	0.79	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	98.22	97.83	27.56	7.87	3.25	5.22	2.95	0.39	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	107.77	92.87	28.46	4.82	3.47	6.39	3.47	0.67	0.22
esophagus, adult, pool1	10015-101C6	106.39	92.80	14.44	7.01	2.34	2.55	1.91	0.53	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	159.68	23.54	10.14	9.52	0.38	0.50	0.50	0.25	0.25
eye - muscle inferior rectus, donor1	10272-104E2	41.05	24.15	0.00	2.41	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	29.46	29.46	8.42	6.31	4.21	2.10	8.42	0.00	0.00
eye - muscle medial, donor2	10299-104H2	17.86	11.91	2.98	8.93	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	42.42	30.96	1.15	1.15	1.15	4.59	5.73	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	27.69	65.58	7.29	0.00	11.66	4.37	14.57	5.83	0.00
eye, fetal, donor1	10054-101G9	79.58	45.76	13.22	11.95	1.53	2.03	1.53	0.51	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	192.72	112.32	29.49	3.21	2.82	6.92	2.18	0.77	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	151.95	76.45	31.34	9.50	4.27	5.94	2.14	0.47	0.71
frontal lobe, adult, pool1	10040-101F4	92.98	30.87	16.14	20.92	6.38	2.06	2.06	0.28	2.53
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	238.70	67.26	30.63	10.51	3.00	2.40	0.30	0.00	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	209.02	51.48	15.18	9.05	1.65	1.37	0.37	0.09	1.10
gall bladder, adult	10198-103E9	98.75	84.98	16.42	7.73	2.41	1.93	2.41	0.48	1.93
gamma delta positive T cells, donor1	11937-126A2	186.29	178.77	15.57	7.52	0.00	2.68	4.29	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	155.75	127.36	13.45	3.73	2.61	4.11	4.48	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	89.56	48.79	9.50	1.90	3.17	2.75	3.17	0.21	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	274.26	79.11	28.43	2.90	1.55	0.97	3.29	0.39	0.58
gastric cancer cell line:AZ521	10549-107H9	123.95	25.41	17.22	9.02	1.15	1.64	1.48	0.33	0.66
gastric cancer cell line:GSS	10560-108A2	161.99	85.12	12.81	2.75	2.75	0.92	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	146.67	71.74	27.87	19.65	2.97	4.11	2.06	0.00	1.37
giant cell carcinoma cell line:LU65	10487-107B1	778.63	204.01	59.44	12.97	5.28	5.05	3.90	0.80	1.49
giant cell carcinoma cell line:Lu99B	10433-106E1	98.53	34.15	7.84	7.42	0.56	0.28	0.56	0.00	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	83.31	78.07	23.45	10.72	2.74	3.49	2.24	0.00	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	73.04	44.33	11.51	5.07	2.01	2.01	0.95	0.11	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	78.79	38.20	13.76	4.21	2.25	2.81	1.12	0.00	0.42
glioblastoma cell line:T98G	10485-107A8	136.31	65.45	18.32	6.84	4.08	2.21	0.88	0.00	0.66
glioma cell line:GI-1	10413-106B8	82.59	62.97	20.50	4.69	2.05	1.76	1.17	0.29	0.59
globus pallidus - adult, donor10196	10175-103C4	91.84	35.72	12.39	10.20	7.29	2.92	3.64	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	114.72	49.06	20.02	20.99	5.61	7.32	2.69	0.24	3.42
globus pallidus, adult, donor10258	10367-105F7	90.37	20.54	10.95	12.32	1.37	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	67.15	44.23	27.71	9.59	4.26	3.73	1.60	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	36.71	428.25	17.13	0.00	73.41	75.86	85.65	9.79	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	382.49	0.00	0.00	0.00	65.57	43.71	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	449.49	10.45	0.00	20.91	26.13	41.81	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	101.44	28.48	12.48	1.92	0.64	1.60	0.96	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	149.67	46.37	20.20	8.72	0.92	0.46	1.38	0.46	2.30
hIPS +CCl2, biol_rep2	14384-156C1	143.58	54.41	16.46	6.86	0.00	0.91	2.74	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	175.84	58.61	25.76	7.09	1.29	1.93	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	172.47	40.24	7.19	14.37	1.44	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	162.55	44.58	17.83	4.80	2.74	1.37	1.37	0.00	0.69
hIPS, biol_rep3	14382-156B8	119.17	20.97	14.35	12.14	4.41	2.21	3.31	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	71.84	83.62	14.94	4.31	0.86	2.87	1.15	0.29	0.57
heart - mitral valve, adult	10205-103F7	80.42	42.45	10.16	10.16	2.09	2.39	0.90	0.30	0.60
heart - pulmonic valve, adult	10206-103F8	50.20	26.15	6.28	16.47	1.57	1.57	0.78	0.52	1.05
heart - tricuspid valve, adult	10207-103F9	87.43	74.11	22.48	2.50	2.50	3.33	1.67	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	81.83	15.30	14.49	5.10	1.84	2.24	2.04	0.00	0.61
heart, adult, diseased, donor1	10051-101G6	35.77	11.50	2.13	3.41	1.70	2.55	0.85	0.00	0.85
heart, adult, pool1	10016-101C7	46.92	38.64	4.60	3.68	2.53	4.60	2.53	0.92	0.23
heart, fetal, pool1	10046-101G1	62.63	35.53	6.98	8.73	1.03	1.95	1.13	0.21	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	159.20	78.98	33.63	1.23	2.78	3.09	2.47	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	162.92	147.46	45.19	11.89	13.08	3.57	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	170.16	46.85	46.74	5.52	1.44	4.42	1.44	0.00	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	167.98	53.40	49.88	6.19	1.58	4.73	0.97	0.24	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	176.03	49.92	45.07	7.48	1.41	5.15	1.31	0.10	0.51
hepatoma cell line:Li-7	10484-107A7	146.25	36.70	18.68	2.45	1.00	1.33	0.78	0.11	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	168.64	181.50	23.22	12.46	4.42	7.54	4.82	1.21	1.21
hippocampus - adult, donor10196	10169-103B7	63.40	27.44	20.82	17.98	4.73	0.95	2.84	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	112.46	32.25	23.88	24.08	4.49	5.71	3.27	0.20	1.43
hippocampus, adult, donor10258	10374-105G5	70.71	26.39	11.45	8.47	10.95	0.00	0.50	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	49.70	25.38	28.20	8.11	7.40	4.93	1.76	1.41	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	191.65	68.97	39.67	16.48	4.27	4.27	3.05	2.44	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	167.49	56.55	26.31	8.25	2.36	1.96	1.77	0.39	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	150.05	62.71	29.45	10.16	3.81	1.52	3.30	0.51	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	88.53	42.85	3.38	7.33	0.56	0.00	1.69	0.56	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	90.12	40.80	8.00	9.04	1.03	0.77	2.84	0.52	1.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	101.36	44.41	9.87	8.73	1.14	0.00	1.52	0.38	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	72.40	28.90	9.34	28.32	1.46	0.29	3.50	0.00	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	77.77	28.65	9.69	14.43	0.65	1.72	2.37	0.22	2.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	84.67	26.69	11.26	17.93	0.83	0.00	3.34	0.00	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	110.11	37.41	22.50	16.58	1.89	3.32	2.84	0.24	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	98.68	40.02	19.13	16.07	1.13	2.57	3.05	0.48	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	120.52	36.36	27.61	18.18	2.69	3.37	4.04	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	148.35	91.70	32.55	10.48	2.82	1.72	2.19	0.47	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	136.09	76.64	37.34	13.26	1.97	2.95	0.98	0.49	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	175.42	82.04	35.78	37.53	2.62	4.36	1.75	0.00	7.85
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	108.63	72.93	10.31	14.32	1.53	0.95	3.25	0.38	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	106.40	58.87	6.98	11.34	0.44	1.31	2.18	0.00	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	106.45	63.47	10.99	17.99	2.00	1.00	4.50	0.50	3.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	98.34	34.85	9.61	9.23	0.57	1.13	1.88	0.38	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	97.31	41.38	7.28	8.64	0.45	0.91	4.09	0.45	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	84.57	35.08	6.58	11.59	0.31	0.31	2.19	0.63	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	96.02	39.19	17.15	15.19	2.45	1.63	1.47	0.00	1.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	94.35	38.61	14.81	13.64	2.03	1.45	1.45	0.00	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	92.67	39.76	12.55	16.14	2.99	1.79	2.99	0.30	2.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	169.97	82.58	33.07	10.16	1.48	2.77	2.77	0.37	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	155.48	71.89	33.95	6.28	3.42	1.14	2.28	1.14	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	204.16	97.59	32.26	13.47	2.86	4.49	0.82	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	103.16	55.28	10.56	12.67	0.00	1.06	1.06	0.70	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	109.91	52.90	10.45	7.29	1.27	0.32	1.58	0.00	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	107.13	59.01	11.20	6.36	0.61	1.51	5.45	0.61	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	86.36	35.16	13.96	15.00	0.52	1.03	3.62	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	97.63	27.23	8.63	9.30	1.33	1.99	1.99	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	82.09	36.43	9.24	14.37	0.77	2.57	1.28	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	102.51	47.29	18.15	8.95	1.02	0.77	2.30	0.51	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	93.90	40.89	21.96	12.87	3.79	0.76	2.27	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	99.47	41.00	20.16	10.08	1.34	3.36	3.36	0.34	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	162.53	74.87	30.19	10.87	0.97	2.17	3.38	0.48	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	188.07	97.60	32.09	17.83	2.23	1.78	3.57	1.78	3.12
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	171.71	68.78	26.83	14.63	2.44	2.44	5.37	1.46	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	101.77	62.35	9.47	10.39	0.61	0.31	2.14	0.31	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	133.38	61.81	6.51	123.62	0.00	0.00	3.25	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	136.35	56.59	13.57	17.54	1.32	0.99	2.32	0.99	4.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	86.47	37.22	10.40	16.42	1.64	1.09	1.64	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	101.33	42.34	9.41	15.92	0.36	2.53	3.98	0.36	3.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	82.21	41.64	6.76	11.74	1.07	0.71	2.85	0.00	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	100.24	34.61	9.55	22.67	1.19	3.58	0.00	0.00	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	117.55	47.81	17.47	15.03	1.63	1.76	2.84	0.27	2.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	76.51	37.45	15.36	12.93	1.08	2.96	2.16	0.81	1.08
immature langerhans cells, donor1	11904-125F5	58.12	121.80	20.58	2.42	18.65	7.02	11.62	0.97	0.24
immature langerhans cells, donor2	11905-125F6	50.70	76.04	20.60	3.17	10.30	3.17	7.13	0.79	0.79
insula, adult, pool1	10039-101F3	104.19	34.35	22.24	13.72	4.92	2.93	2.27	0.28	1.14
keratoacanthoma cell line:HKA-1	10791-110H8	145.02	117.38	28.29	3.25	2.60	2.28	3.90	0.33	0.33
kidney, adult, pool1	10017-101C8	131.87	65.18	19.32	11.41	5.41	3.50	4.61	1.00	0.80
kidney, fetal, pool1	10045-101F9	130.72	62.53	16.20	5.94	1.98	2.48	3.47	0.35	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	82.37	64.34	15.62	1.99	1.28	1.56	0.85	0.14	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	70.50	73.41	9.54	2.07	0.28	0.69	0.83	0.28	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	195.61	144.96	31.93	14.68	8.07	5.87	1.65	0.00	1.47
left atrium, adult, donor1	10079-102A7	35.42	32.69	0.54	7.08	4.36	1.09	2.18	0.00	1.09
left ventricle, adult, donor1	10078-102A6	34.89	24.27	1.01	1.01	4.55	2.02	2.02	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	129.69	17.78	13.68	2.19	0.55	1.64	0.82	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	127.53	63.95	38.44	6.83	6.47	5.03	1.80	1.80	0.36
leiomyoma cell line:15242A	10570-108B3	120.11	53.26	33.15	3.80	6.52	3.26	3.80	1.09	0.54
leiomyoma cell line:15425	10571-108B4	143.50	37.15	33.99	5.58	3.40	2.43	1.94	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	120.64	57.14	31.75	0.00	6.35	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	25.09	31.37	7.32	1.05	1.05	3.14	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	107.20	133.17	24.79	4.72	4.13	13.46	2.60	0.35	0.35
liposarcoma cell line:KMLS-1	10782-110G8	99.19	29.06	11.25	2.81	1.72	1.09	0.47	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	46.66	30.83	5.36	4.75	1.46	1.22	0.61	0.12	0.37
liver, adult, pool1	10018-101C9	396.89	103.72	96.91	2.76	6.32	6.81	2.27	1.62	0.32
liver, fetal, pool1	10086-102B5	139.23	51.74	29.16	0.94	4.70	5.64	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	60.52	26.69	13.56	14.14	5.54	2.04	2.77	0.44	1.46
locus coeruleus, adult, donor10252	10165-103B3	87.11	24.18	15.69	17.72	2.40	3.88	3.14	0.18	0.92
locus coeruleus, adult, donor10258	10375-105G6	75.33	24.26	14.95	9.31	3.67	1.13	3.10	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	90.43	46.69	28.60	32.81	3.79	4.21	0.42	0.84	2.52
lung adenocarcinoma cell line:A549	10499-107C4	291.32	77.09	62.83	4.15	3.04	3.88	1.94	0.28	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	84.80	83.42	11.03	13.10	4.14	2.76	2.76	0.00	2.76
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	126.28	40.60	17.27	6.46	0.92	1.58	1.05	0.26	0.66
lung, adult, pool1	10019-101D1	141.04	191.84	26.70	3.66	9.92	7.80	12.88	2.01	0.59
lung, fetal, donor1	10068-101I5	175.24	137.85	44.81	21.98	7.14	3.14	2.00	0.29	4.00
lung, right lower lobe, adult, donor1	10075-102A3	120.97	108.60	40.32	5.96	6.42	5.96	7.33	1.37	1.37
lymph node, adult, donor1	10077-102A5	71.95	199.76	10.41	1.42	10.41	8.99	13.73	3.31	0.47
lymphangiectasia cell line:DS-1	10727-110A7	183.89	229.70	23.89	2.85	5.92	11.40	8.33	1.53	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	71.84	136.74	13.13	28.22	17.81	13.13	13.89	1.51	2.11
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	183.49	70.51	23.79	17.84	2.55	3.40	0.85	1.70	0.85
mature adipocyte, donor1	12231-129F8	99.45	48.84	17.32	9.32	0.44	2.66	1.78	0.00	0.89
mature adipocyte, donor2	12232-129F9	116.63	45.86	11.41	6.43	1.25	5.19	0.42	0.00	1.04
mature adipocyte, donor3	12233-129G1	97.67	36.27	16.12	9.48	1.66	2.61	0.71	0.00	0.47
mature adipocyte, donor4	12234-129G2	111.34	55.28	13.42	11.06	2.11	2.11	1.32	0.26	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	454.36	138.19	75.29	15.73	10.01	7.15	4.53	2.86	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	90.24	21.43	14.66	5.64	4.51	3.38	1.13	0.00	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	95.82	27.59	16.92	20.05	2.39	2.76	2.39	0.55	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	59.09	22.24	10.48	9.53	6.67	1.59	2.86	0.32	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	49.47	28.15	19.62	34.55	5.12	5.97	2.99	0.00	4.26
medial temporal gyrus - adult, donor10196	10183-103D3	78.81	29.03	16.88	19.41	5.06	4.22	2.36	0.17	1.86
medial temporal gyrus, adult, donor10252	10156-103A3	94.02	29.50	19.10	21.86	4.67	4.24	2.12	0.64	1.27
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	61.64	23.12	9.63	11.56	7.71	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	14.35	0.00	114.83	0.00	0.00	28.71	0.00	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	60.30	36.25	28.00	12.92	8.61	5.03	1.44	0.00	2.51
medulla oblongata - adult, donor10196	10174-103C3	98.00	42.83	18.82	12.98	3.89	3.89	3.24	0.65	3.24
medulla oblongata, adult, donor10252	10155-103A2	105.27	34.52	15.02	20.43	2.94	5.73	2.79	0.62	2.01
medulla oblongata, adult, pool1	10038-101F2	85.63	35.51	9.96	10.86	4.24	2.78	2.61	0.41	1.96
medulla oblongata, newborn, donor10223	10361-105F1	96.86	46.52	29.16	19.79	3.47	4.86	2.43	1.39	0.69
medulloblastoma cell line:D283 Med	10838-111E1	117.35	60.22	20.37	4.43	1.11	0.22	0.66	0.00	0.89
medulloblastoma cell line:ONS-76	10759-110E3	85.47	32.40	13.33	3.91	1.10	2.81	1.10	0.24	0.61
melanoma cell line:COLO 679	10514-107E1	127.07	35.07	21.13	7.47	1.01	1.01	1.15	0.57	0.57
melanoma cell line:G-361	10465-106H6	129.22	49.68	10.59	3.26	0.81	1.36	2.44	1.90	0.81
meningioma cell line:HKBMM	10691-109F7	143.10	95.34	20.80	4.16	1.63	3.26	1.27	0.54	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	123.36	51.99	16.74	19.39	1.76	1.76	1.76	0.00	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	106.28	31.11	14.78	14.26	0.26	1.30	0.78	0.26	1.56
mesenchymal precursor cell - adipose, donor1	11747-123G1	185.81	49.25	32.53	1.23	1.53	1.84	0.61	0.31	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	117.79	50.54	35.08	2.36	1.09	1.64	0.91	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	101.46	32.71	15.32	5.80	0.41	1.24	0.83	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	54.36	31.61	11.10	2.53	0.84	0.56	0.28	0.42	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	69.71	47.76	13.09	4.04	0.58	0.39	0.96	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	110.36	22.90	18.74	3.47	0.00	0.69	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	134.90	105.21	56.98	2.06	2.92	2.40	2.06	0.86	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	93.05	41.98	16.10	0.69	0.46	0.81	0.81	0.58	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	120.70	36.87	21.35	1.72	2.12	1.46	0.80	0.40	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	115.46	56.58	41.46	3.65	4.19	2.70	1.08	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	112.25	54.20	45.24	2.70	1.71	2.13	0.85	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	137.34	93.87	37.22	0.66	1.98	1.98	1.65	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	119.83	47.46	27.12	2.08	1.94	1.66	0.55	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	173.84	52.71	30.02	2.79	1.05	1.75	0.70	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	118.42	50.43	23.27	2.04	2.45	1.02	0.61	0.41	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	120.42	44.57	20.49	1.08	1.08	1.44	0.36	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	82.04	36.93	12.72	1.55	0.93	0.41	0.72	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	70.68	27.59	22.12	1.14	2.51	3.19	1.37	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	74.68	32.73	18.46	4.62	1.26	1.68	0.84	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	105.05	44.08	24.96	1.49	1.20	1.34	0.30	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	121.32	59.17	34.22	2.01	1.58	1.66	1.05	0.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	100.51	67.74	15.46	1.47	0.74	1.84	1.84	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	86.42	31.76	16.02	0.86	1.14	1.43	0.57	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	72.84	16.00	6.74	5.05	2.53	1.26	0.84	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	117.36	40.64	24.66	0.91	0.46	0.46	0.46	1.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	128.15	31.97	19.95	2.81	1.53	1.02	0.00	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	146.06	39.53	16.49	4.71	0.52	1.83	1.31	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	127.55	40.36	16.64	3.39	1.54	1.23	0.31	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	117.91	31.07	13.18	2.59	0.94	0.71	0.24	0.47	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	125.91	41.63	15.23	3.38	1.35	2.37	1.02	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	123.79	44.41	12.58	1.57	0.00	1.18	1.57	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	125.58	42.17	13.44	2.32	0.93	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	193.21	96.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	141.61	34.32	17.02	4.61	2.60	2.02	0.87	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	128.51	38.82	15.17	1.34	1.34	1.12	0.89	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	140.37	40.86	16.34	1.92	1.68	1.68	0.72	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	114.40	35.20	14.67	5.13	0.00	1.47	0.00	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	110.77	34.91	14.77	1.68	0.67	1.34	1.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	120.77	43.39	11.05	2.87	1.64	1.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	119.42	42.10	15.89	3.87	2.15	0.43	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	112.11	54.69	27.34	0.00	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	129.12	25.82	10.33	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	118.87	45.47	19.16	2.60	1.30	2.60	1.30	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	114.94	40.74	13.09	2.91	0.00	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	130.60	42.65	18.12	4.26	4.80	0.53	0.53	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	112.03	33.53	17.99	4.09	0.82	0.00	1.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	115.45	44.31	13.99	2.33	0.00	1.17	0.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	83.95	39.88	14.69	2.10	0.00	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	122.20	41.73	18.88	1.99	1.99	0.99	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	109.65	28.60	19.07	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	100.80	41.51	13.64	2.96	2.37	0.59	1.19	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	93.82	42.65	15.84	4.87	1.22	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	27.05	27.05	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	105.14	37.37	10.13	3.80	1.27	0.63	1.27	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	105.89	47.25	19.31	3.10	0.69	0.34	1.38	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	83.82	62.33	4.30	2.15	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	107.78	71.85	7.98	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	123.98	51.66	20.66	3.44	0.00	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	107.16	52.97	11.41	3.67	2.04	0.81	1.63	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	129.49	59.58	13.51	5.56	0.79	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	99.04	58.36	18.28	6.48	0.00	0.59	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	101.93	67.33	14.65	3.43	1.25	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	113.62	84.21	26.73	8.02	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	85.15	57.95	18.92	2.37	1.18	0.00	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	97.58	64.20	25.68	2.57	2.57	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	105.32	45.43	28.91	2.07	0.00	0.69	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	131.12	50.47	27.71	1.98	1.98	1.98	1.48	1.48	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	118.88	57.20	31.40	3.36	1.12	4.49	1.12	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	124.67	52.16	32.44	1.91	1.27	3.82	2.54	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	164.01	48.36	35.87	2.82	2.82	4.03	2.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	183.17	47.97	26.17	2.18	0.00	0.00	4.36	4.36	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	119.10	48.15	34.21	1.27	7.60	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	202.70	69.19	67.36	1.82	1.82	4.25	1.82	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	388.63	99.42	103.94	4.52	0.00	4.52	0.00	4.52	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	261.11	70.01	62.60	2.47	6.59	4.94	2.47	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	132.15	57.54	21.63	3.17	0.99	0.79	0.00	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	121.69	38.29	15.58	2.92	0.97	1.62	0.97	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	100.84	39.73	15.28	2.04	1.02	1.02	2.04	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	73.50	39.46	8.51	3.87	0.00	3.87	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	322.23	41.34	23.86	1.89	1.89	1.89	1.42	0.71	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	222.41	101.70	66.49	2.78	5.56	12.28	2.78	0.46	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	106.84	47.01	12.82	4.27	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	157.93	103.06	37.09	6.88	2.77	6.58	2.26	0.21	0.41
mesothelioma cell line:Mero-25	10850-111F4	158.64	64.45	30.18	2.04	3.18	4.09	1.36	0.45	0.45
mesothelioma cell line:Mero-41	10851-111F5	144.97	48.16	21.27	1.71	1.22	0.98	0.24	0.49	0.49
mesothelioma cell line:Mero-48a	10852-111F6	97.65	46.94	21.70	2.88	2.66	2.88	1.11	0.44	0.44
mesothelioma cell line:Mero-82	10853-111F7	91.19	70.43	18.13	3.68	1.84	1.58	1.84	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	76.60	48.17	16.00	3.23	1.53	2.21	0.68	0.34	0.17
mesothelioma cell line:Mero-84	10855-111F9	100.86	54.60	15.92	1.52	1.01	3.29	0.51	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	96.48	49.48	18.43	2.07	2.07	2.90	1.45	0.41	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	81.50	56.82	23.69	2.82	3.15	4.97	1.49	0.00	0.33
mesothelioma cell line:NCI-H226	10846-111E9	92.49	70.41	23.35	5.79	1.45	6.52	2.90	0.18	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	134.95	61.67	14.86	7.17	2.22	4.95	2.05	0.34	0.85
mesothelioma cell line:NCI-H28	10845-111E8	59.55	39.19	5.34	3.05	1.02	0.51	2.54	0.25	0.25
mesothelioma cell line:No36	10857-111G2	92.32	45.99	12.40	3.91	0.98	0.98	1.30	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	187.23	57.71	23.03	1.08	1.63	1.63	0.54	0.81	0.00
migratory langerhans cells, donor1	11901-125F2	87.52	79.84	10.94	12.86	3.26	3.65	2.69	0.19	1.73
migratory langerhans cells, donor2	11902-125F3	62.52	58.37	9.28	8.06	2.20	2.56	1.34	0.37	0.49
migratory langerhans cells, donor3	11903-125F4	63.18	112.89	4.67	14.36	2.15	1.79	3.05	0.72	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	194.58	35.26	12.41	3.26	1.31	0.33	1.31	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	172.30	23.95	18.65	2.54	1.48	1.48	0.21	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	199.49	104.81	35.48	8.29	5.53	5.53	1.84	0.46	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	61.46	62.80	11.61	3.81	1.14	1.33	0.76	0.76	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	61.91	316.92	17.74	9.98	8.32	20.70	22.91	2.96	0.74
myeloma cell line:PCM6	10474-106I6	300.85	496.54	53.17	65.03	16.41	16.01	10.48	2.97	1.98
myxofibrosarcoma cell line:MFH-ino	10600-108E6	88.78	44.13	11.16	2.03	2.03	0.51	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	109.25	40.01	21.97	5.10	1.77	2.16	0.78	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	297.95	85.24	26.30	8.91	1.45	0.78	0.56	0.22	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	305.41	84.50	35.52	9.93	1.47	1.62	0.74	0.15	0.66
nasal epithelial cells, donor2	12227-129F4	202.58	97.15	30.91	4.97	3.31	1.10	0.55	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	105.14	108.82	28.53	24.39	0.69	2.07	2.99	0.23	1.38
neuroblastoma cell line:NB-1	10539-107G8	87.56	49.58	16.09	17.02	0.56	1.68	1.31	0.19	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	202.66	49.35	25.10	2.53	1.27	2.32	0.42	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	71.37	70.81	8.76	19.57	1.68	0.93	2.05	0.00	1.68
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	57.65	109.84	10.20	7.35	0.71	0.71	1.19	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	69.69	39.91	8.55	5.70	0.16	1.11	0.63	0.16	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	186.77	101.03	12.48	10.87	0.60	1.01	1.01	0.40	1.61
neuroepithelioma cell line:SK-N-MC	10728-110A8	127.15	69.93	12.72	3.18	0.64	0.64	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	133.08	20.76	19.96	0.80	1.33	3.73	0.53	0.00	0.27
neutrophil PMN, donor1	12133-128D9	0.00	44.62	0.00	0.00	89.25	29.75	44.62	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	159.37	0.00	0.00	26.56	26.56	26.56	26.56	0.00
neutrophil PMN, donor3	12141-128E8	18.94	132.59	0.00	0.00	47.35	9.47	37.88	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	87.77	222.90	14.88	18.77	4.23	7.78	4.40	1.01	1.35
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	125.68	36.02	23.21	12.81	1.60	0.00	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	162.87	55.79	24.37	1.60	0.32	3.21	0.64	1.28	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	126.13	35.74	18.13	2.10	1.84	1.05	1.05	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	104.71	34.78	17.53	16.87	2.72	2.34	2.25	0.19	1.97
occipital cortex - adult, donor10196	10172-103C1	76.23	6.18	22.66	26.78	4.12	0.00	0.00	0.00	4.12
occipital cortex, adult, donor10252	10163-103B1	101.17	32.47	14.49	24.42	3.76	5.10	4.56	0.54	2.68
occipital cortex, newborn, donor10223	10355-105E4	61.51	30.94	23.29	14.19	8.73	3.28	1.82	0.00	0.73
occipital lobe, adult, donor1	10076-102A4	67.17	26.24	19.16	11.02	3.67	2.62	2.36	0.26	1.31
occipital lobe, fetal, donor1	10073-102A1	75.09	24.46	11.16	21.03	0.86	0.43	1.72	0.43	1.29
occipital pole, adult, pool1	10036-101E9	72.22	20.42	8.83	5.83	3.15	1.34	1.10	0.08	0.71
olfactory region, adult	10195-103E6	73.94	25.22	14.90	18.91	2.67	1.91	0.57	0.00	1.72
optic nerve, donor1	10277-104E7	70.04	22.01	14.01	18.01	2.00	2.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	251.74	105.71	52.40	23.12	5.35	5.24	1.59	1.25	2.16
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	339.62	53.72	20.75	8.93	1.92	1.24	0.82	0.00	1.79
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	80.60	56.22	10.67	5.93	1.02	1.19	0.85	0.00	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	130.87	95.29	13.98	7.39	3.58	2.66	3.12	0.23	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	109.65	42.04	8.23	0.59	1.47	0.00	0.59	1.18	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	116.79	154.17	28.03	2.80	5.61	3.74	2.80	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	157.14	45.80	32.02	2.97	1.27	1.27	0.42	0.42	1.06
ovary, adult, pool1	10020-101D2	122.55	77.57	18.78	10.92	2.27	2.01	2.10	0.44	1.05
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	107.79	59.95	29.33	1.10	3.30	4.77	0.73	0.18	0.18
pancreas, adult, donor1	10049-101G4	553.10	279.37	198.47	5.64	11.29	6.58	4.70	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	81.90	30.19	8.39	5.59	1.12	0.84	0.56	0.28	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	79.55	64.73	10.90	5.45	5.28	4.09	1.02	0.17	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	94.71	88.09	15.23	6.13	1.82	2.32	0.50	0.00	0.33
paracentral gyrus, adult, pool1	10035-101E8	85.30	24.44	14.55	10.98	3.84	1.83	1.56	0.09	1.10
parietal cortex, adult, donor10258	10373-105G4	91.75	19.82	14.68	9.54	2.20	0.73	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	68.66	27.27	11.29	19.75	7.52	0.94	0.00	0.00	2.82
parietal lobe, adult, donor10252	10157-103A4	91.78	20.81	15.11	14.25	3.99	3.99	1.43	0.29	0.57
parietal lobe, adult, pool1	10034-101E7	86.53	28.73	16.04	10.57	4.58	2.38	2.03	0.26	1.50
parietal lobe, fetal, donor1	10072-101I9	70.80	13.58	13.58	22.31	4.85	1.94	1.94	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	69.91	32.53	27.67	15.33	7.48	3.74	1.12	0.00	0.75
parotid gland, adult	10199-103F1	284.90	519.85	141.83	20.97	52.42	60.43	25.28	1.85	0.00
penis, adult	10200-103F2	75.73	30.62	4.83	7.52	0.54	4.30	1.07	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	95.57	30.87	6.14	4.46	0.19	0.56	0.37	0.19	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	181.24	88.29	24.33	5.83	4.37	3.35	2.62	0.44	0.58
pineal gland - adult, donor10196	10179-103C8	54.18	23.22	12.90	34.83	1.94	1.29	1.94	0.00	1.29
pineal gland, adult, donor10252	10160-103A7	63.96	20.14	7.11	58.04	3.55	4.15	2.37	0.00	3.55
pineal gland, adult, donor10258	10377-105G8	39.51	19.44	7.52	26.34	2.51	0.00	2.51	0.00	3.76
pituitary gland - adult, donor10196	10180-103C9	323.78	75.89	72.85	43.51	2.02	3.04	3.04	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	271.01	45.34	51.08	69.32	2.61	4.69	3.13	0.00	5.73
pituitary gland, adult, donor10258	10378-105G9	257.08	57.03	42.56	37.45	1.70	3.40	4.26	0.00	2.55
placenta, adult, pool1	10021-101D3	171.04	52.03	23.01	8.06	3.44	3.33	2.04	0.32	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	194.40	186.72	35.09	16.29	3.71	6.36	1.59	0.26	1.46
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	160.15	65.37	25.06	6.38	1.25	2.49	1.09	0.16	0.62
pons, adult, pool1	10033-101E6	64.46	21.26	7.23	14.63	3.44	1.38	3.18	0.17	1.81
postcentral gyrus, adult, pool1	10032-101E5	81.51	22.23	12.55	7.93	2.88	2.53	1.31	0.35	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	299.07	6.27	0.00	71.11	108.75	158.95	10.46	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	60.59	451.66	11.02	0.00	16.52	33.05	93.64	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	328.60	0.00	0.00	58.68	70.41	105.62	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	116.38	34.23	10.63	7.43	3.20	1.31	0.58	0.15	0.44
prostate cancer cell line:PC-3	10439-106E7	286.05	83.67	41.93	23.23	3.99	3.45	2.18	0.91	2.72
prostate, adult, pool1	10022-101D4	141.21	93.68	25.85	15.24	3.90	3.26	3.36	1.54	0.82
putamen, adult, donor10196	10176-103C5	112.13	36.59	24.08	29.98	3.54	4.49	0.94	0.24	2.36
putamen, adult, donor10252	10152-102I8	117.64	60.78	19.61	19.61	3.92	3.92	3.92	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	101.63	19.67	7.65	16.39	3.28	1.09	3.28	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	89.40	28.03	14.74	13.05	1.93	1.21	1.69	0.72	0.24
putamen, newborn, donor10223	10365-105F5	114.70	32.99	34.48	26.99	7.50	6.00	0.75	0.75	3.75
rectal cancer cell line:TT1TKB	10469-106I1	166.12	170.20	69.53	4.07	5.24	5.53	2.04	0.58	0.00
rectum, fetal, donor1	10067-101I4	83.46	80.68	15.30	6.95	8.35	2.78	4.17	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	287.26	43.46	19.93	3.60	3.82	2.76	0.64	0.00	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	250.60	64.20	22.78	2.49	0.00	0.41	0.41	0.00	0.41
retina, adult, pool1	10030-101E3	97.81	44.23	11.73	9.84	2.98	2.29	1.59	0.50	1.49
retinoblastoma cell line:Y79	10475-106I7	54.04	43.13	7.01	6.50	0.52	0.00	1.82	0.00	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	87.05	8.36	6.39	5.90	0.37	0.49	0.12	0.00	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	234.52	154.10	34.31	5.06	5.06	3.09	1.97	0.00	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	113.68	64.42	12.13	6.82	6.82	0.00	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	66.36	78.18	10.68	3.88	1.46	0.97	0.81	0.00	0.32
salivary acinar cells, donor2	11772-123I8	61.96	82.06	6.88	7.16	0.55	0.14	0.83	0.00	0.28
salivary acinar cells, donor3	11773-123I9	47.01	93.35	10.59	5.96	2.65	1.99	1.99	0.00	0.66
salivary gland, adult, pool1	10093-102C3	253.95	439.26	110.39	17.16	50.90	9.15	16.01	1.14	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	114.58	67.79	12.90	4.72	0.59	1.77	1.52	0.34	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	117.79	60.07	10.11	3.53	1.76	1.76	0.94	0.24	0.35
seminal vesicle, adult	10201-103F3	205.28	202.11	71.42	13.76	13.23	17.99	5.29	3.17	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	152.07	66.32	41.54	8.50	3.40	3.89	1.94	0.73	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	83.04	43.03	12.33	0.75	1.01	2.01	1.01	0.75	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	137.48	32.11	24.08	0.00	1.00	4.01	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	125.86	60.58	24.45	0.67	4.03	3.09	1.88	0.27	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	132.08	69.41	13.59	4.97	2.32	2.54	2.43	0.22	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	91.61	135.61	24.26	9.16	2.58	5.94	4.52	0.77	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	27.66	4.97	0.71	8.51	0.71	0.71	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	36.10	30.58	3.00	11.03	1.32	1.80	0.36	0.12	0.36
skeletal muscle, fetal, donor1	10066-101I3	62.31	29.15	3.02	4.02	1.01	0.00	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	74.64	61.07	6.79	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	115.51	54.29	12.62	12.62	0.63	1.26	0.63	0.63	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	99.06	27.02	10.67	4.34	2.00	2.00	1.00	0.33	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	67.14	48.86	12.92	32.78	5.04	2.21	0.63	0.00	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	127.21	14.84	10.41	2.89	1.93	0.19	0.39	0.00	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	121.31	78.29	18.63	21.10	4.12	1.98	1.65	0.00	2.47
small cell lung carcinoma cell line:NCI-H82	10842-111E5	296.29	142.19	35.23	2.57	0.80	0.80	1.13	0.32	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	180.65	75.84	36.39	57.31	9.15	5.67	4.14	0.87	2.83
small intestine, adult, pool1	10024-101D6	142.02	160.29	24.72	8.60	9.56	5.49	6.69	2.27	0.84
small intestine, fetal, donor1	10064-101I1	113.27	94.10	15.72	5.65	2.70	2.46	2.46	0.25	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	149.77	63.60	22.05	11.80	7.18	2.05	1.54	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	66.16	26.36	4.39	9.82	1.03	0.78	0.52	0.26	0.78
somatostatinoma cell line:QGP-1	10781-110G7	123.29	172.87	44.76	6.70	9.38	9.11	3.75	0.00	1.34
spinal cord - adult, donor10196	10181-103D1	75.25	38.31	12.62	15.37	5.74	4.13	4.36	0.69	1.84
spinal cord, adult, donor10252	10159-103A6	81.22	56.77	13.01	17.35	9.07	4.34	8.28	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	89.93	24.21	11.76	21.45	2.08	0.00	2.08	0.00	2.08
spinal cord, fetal, donor1	10056-101H2	95.74	35.98	12.20	13.42	3.05	2.44	3.66	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	80.36	53.73	16.07	23.88	6.43	8.27	3.67	1.38	3.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	135.17	57.05	23.75	0.45	2.54	2.84	1.19	0.45	0.00
spleen, adult, pool1	10025-101D7	83.48	200.44	15.86	4.96	14.65	14.32	16.74	2.53	0.44
spleen, fetal, pool1	10044-101F8	79.46	108.30	12.71	2.38	5.32	6.67	7.07	0.87	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	61.49	120.90	11.90	23.50	1.97	5.07	3.62	0.52	2.59
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	164.81	78.80	20.70	11.96	2.47	2.47	1.52	0.19	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	144.67	30.05	23.06	9.44	1.75	2.10	1.75	0.35	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	202.50	161.85	60.59	34.01	7.04	8.21	1.17	0.39	5.08
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	345.89	129.44	58.98	58.19	10.69	7.32	4.28	0.56	5.85
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	167.32	38.12	24.15	7.20	0.00	1.69	1.27	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	118.46	67.27	33.85	5.92	1.69	2.96	1.27	0.42	0.00
stomach, fetal, donor1	10062-101H8	110.00	96.12	25.63	5.34	3.20	5.34	4.27	1.07	0.00
submaxillary gland, adult	10202-103F4	200.53	410.17	76.91	24.50	37.03	40.45	10.82	2.28	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	92.01	35.73	14.54	16.41	2.70	5.19	4.15	1.04	1.66
substantia nigra, adult, donor10258	10371-105G2	84.31	19.66	5.69	8.79	3.62	1.03	1.03	0.00	1.55
substantia nigra, newborn, donor10223	10358-105E7	74.90	36.04	21.90	12.01	6.36	3.53	4.95	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	109.82	36.91	17.19	2.06	0.00	0.92	0.46	0.23	0.69
temporal lobe, adult, pool1	10031-101E4	71.72	27.13	12.04	6.27	3.90	1.86	1.36	0.25	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	67.67	44.87	13.53	14.25	2.14	0.00	2.85	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	61.97	40.44	7.03	20.22	0.00	2.20	1.32	0.00	2.64
tenocyte, donor1	11763-123H8	149.42	46.43	17.46	2.09	1.75	2.79	0.00	0.00	1.05
tenocyte, donor2	11765-123I1	85.84	43.87	11.83	2.67	0.00	1.14	0.38	0.38	0.00
tenocyte, donor3	11768-123I4	139.74	43.37	23.35	2.22	2.22	1.48	0.37	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	159.76	45.72	17.51	11.05	1.53	2.72	0.85	0.34	1.70
teratocarcinoma cell line:NCR-G1	10798-110I6	120.70	34.99	12.49	3.08	0.31	1.08	0.62	0.31	0.62
teratocarcinoma cell line:PA-1	10807-111A6	110.50	66.64	12.71	4.18	2.17	1.24	1.55	0.15	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	220.63	84.42	45.32	1.90	2.67	5.20	2.54	2.29	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	156.56	75.63	19.66	7.56	1.51	0.38	3.03	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	68.16	89.10	15.70	5.45	1.74	1.09	2.18	0.55	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	120.51	28.34	11.07	6.51	1.30	0.33	1.95	0.65	1.30
testis, adult, pool1	10026-101D8	125.95	66.46	19.97	9.66	7.62	4.83	4.94	1.61	1.93
testis, adult, pool2	10096-102C6	101.95	29.32	19.85	8.57	7.22	2.26	4.06	1.35	2.26
thalamus - adult, donor10196	10168-103B6	102.67	23.18	13.25	18.77	0.00	3.31	4.42	0.00	1.10
thalamus, adult, donor10252	10154-103A1	99.08	34.38	17.03	19.54	2.97	4.53	3.44	0.31	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	112.39	24.63	4.62	21.55	3.08	0.00	3.08	0.00	6.16
thalamus, adult, donor10258, tech_rep2	10370-105G1	58.79	19.27	7.58	7.91	4.28	1.98	2.31	0.49	1.15
thalamus, newborn, donor10223	10366-105F6	66.74	28.77	33.94	9.78	5.18	5.75	0.00	1.15	0.00
throat, adult	10209-103G2	76.40	77.40	15.98	16.48	4.74	5.99	2.00	0.50	0.25
throat, fetal, donor1	10061-101H7	91.41	43.27	11.58	12.19	3.05	1.22	2.13	0.30	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	128.98	49.29	16.89	13.91	0.40	0.60	0.20	0.00	0.60
thymus, adult, pool1	10027-101D9	133.02	175.17	24.65	10.34	2.29	2.98	2.58	0.99	1.39
thymus, fetal, pool1	10043-101F7	112.42	132.37	20.16	13.51	3.01	4.78	3.01	1.14	1.14
thyroid carcinoma cell line:KHM-5M	10776-110G2	127.64	82.04	33.11	3.59	2.39	2.93	2.26	0.53	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	159.25	112.45	21.23	5.45	3.77	4.47	3.21	0.42	0.56
thyroid, adult, pool1	10028-101E1	291.23	125.79	46.94	13.16	6.44	6.53	3.27	1.31	1.31
thyroid, fetal, donor1	10060-101H6	155.30	45.61	23.99	15.56	5.54	2.64	2.64	0.26	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	73.91	76.99	12.32	3.08	9.24	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	63.96	39.31	11.86	11.63	2.33	2.56	1.16	0.23	0.00
tongue, fetal, donor1	10059-101H5	65.03	42.96	8.67	7.09	6.31	1.58	1.58	0.00	0.39
tonsil, adult, pool1	10047-101G2	128.63	183.22	19.53	6.41	4.01	6.41	5.21	0.30	0.80
trachea, adult, pool1	10029-101E2	162.12	174.97	40.49	7.12	10.80	10.31	7.03	1.23	0.41
trachea, fetal, donor1	10058-101H4	120.79	102.71	37.70	5.77	5.00	7.69	3.08	0.77	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	147.38	62.71	29.40	1.42	2.48	2.48	1.77	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	129.48	83.89	34.14	7.09	6.89	4.86	2.43	0.20	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	194.92	105.92	30.40	13.32	0.94	2.51	2.51	0.47	1.25
tridermal teratoma cell line:HGRT	10694-109G1	79.91	49.47	11.42	0.00	3.81	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	82.70	57.82	9.57	1.52	1.78	1.10	1.52	0.08	0.08
umbilical cord, fetal, donor1	10057-101H3	70.94	25.04	4.17	6.26	2.09	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	103.91	51.53	18.26	10.92	0.17	0.85	0.85	0.00	0.68
uterus, fetal, donor1	10055-101H1	105.46	51.19	12.80	7.17	1.54	1.02	4.61	0.00	0.51
vagina, adult	10204-103F6	93.05	93.05	27.14	0.65	1.94	3.23	5.17	0.65	0.00
vein, adult	10191-103E2	82.64	122.09	11.18	7.67	1.97	5.92	4.16	0.66	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	79.04	132.72	10.41	12.55	1.60	1.60	2.40	0.53	0.27